Adult Medicine Ambulatory Care Cardiology Central Nervous System Clinical Administration Critical Care Drug Information

Education and Training Emergency Medicine Endocrine and Metabolism Geriatrics GI/Liver/Nutrition Hematology/Oncology Immunology/Transplantation

Infectious Diseases Nephrology Pain and Palliative Care Pediatrics PK/PD/PG Women’s Health

The Adult Medicine PRN has been actively planning two focus sessions for the ACCP Annual Meeting. Our PRN membership was polled last year for suggested educational session topics. Based on the results, the PRN has been coordinating with the Infectious Diseases PRN to offer an update on HIV topics for the general practitioner. The PRN is also planning another focus session for the ACCP Annual Meeting, tentatively an update of chronic obstructive pulmonary disorder management.

The Travel and Training and Nominations committees continue to work on new awards to recognize our PRN members. Stay tuned for announcements regarding these awards.

Promotions:
Lamis Karaoui, Pharm.D., BCPS, was appointed director of experiential education – Department of Pharmacy Practice, School of Pharmacy, Lebanese American University, Byblos, Lebanon.

Posters:
Lamis Karaoui, Pharm.D., BCPS, presented a poster titled “Efficacy and Safety of Enoxaparin 20 mg Subcutaneously in Patients with Chronic Kidney Disease Stages 4 and 5 for Deep Vein Thrombosis” at the 2012 SCCM (Society of Critical Care Medicine) Congress.

Lamis Karaoui, Pharm.D., BCPS, presented a poster titled “Evaluation of Diabetes Awareness Among Patients with Diabetes Mellitus Within Lebanese Community Pharmacy Practice Settings” at the 2011 ASHP Midyear Clinical Meeting & Exhibition.

Other notable achievements:
Adrienne Carey, clinical pharmacist at Freeman Health System, is now BCPS certified.

The Ambulatory Care PRN continues to thrive, with more than 1300 members. Some notable achievements of individuals from the Ambulatory Care membership during the past year are as follows.

Awards:
Sarah Westberg recently received the Young Alumni Achievement Award from Drake University College of Pharmacy and Health Sciences.

Stephanie Nigro and Christina Madison were both recipients of APhA’s 2012 One to One Counseling Recognition Award.

Kathryn Hurren received the Pharmacist of the Year Award from the Southeastern Michigan Society of Health-System Pharmacists.

Debra Wobbleton Kemp was awarded the 2011 North Carolina Distinguished Young Pharmacist Award.

Grants:
Stephanie Nigro received a $1000 APhA foundation grant for a project titled "Impact of Pharmacist-Generated Asthma Action Plans to Improve Asthma Control in an FQHC."

Emily McCoy was a coadvisor for a student-developed MTM program at an indigent patient pharmacy (Ozanam Charitable Pharmacy) that received a $7000 award from Target, and she received a grant from the Alabama Asthma Program together with a colleague, Allison Chung, to develop a hands-on skills-based asthma program for local practitioners.

Publications:
Tzefos M, Harris K, Brackett A. Clinical efficacy and safety of once-weekly glucagon-like peptide-1 agonists in development for treatment of type 2 diabetes mellitus in adults. Ann Pharmacother 2012;46:68–78.

Tzefos M, Olin J. 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy. J Clin Lipidol 2011;5:450–9.

Brice K, Tzefos M. The clinical efficacy and safety of glucagon-like peptide-1 (GLP-1) agonists in adults with type 2 diabetes mellitus. Clin Med Insights Endocrinol Diab 2011;4:13–24.

Colon-Emeric C, O’Connell MB, Haney E. Osteoporosis piece of multi-morbidity puzzle in geriatric care. Mt Sinai J Med 2011;78:515–26.

Benge C, Markley B, McFarland M. Role of aggressive LDL reduction in patients with coronary heart disease. South Med J 2012;105:48–55.

McFarland M, Markley B, Zhang P, Hudson J. Evaluation of modification of diet in renal disease study and Cockcroft-Gault equations for sitagliptin dosing. J Nephrol 2011 Sep 7:0. doi:10.5301/jn.5000026.

Riddle S. Taking CDS to the next level for medication management. Patient Saf Qual Healthc 2012;9:14–6.

Nigro S and Smith M cowrote a PSAP chapter titled “The Patient-Centered Medical Home” (Book 8 in October 2011).

Ward L, Patel NM, Hanlon A, Eldakar-Hein S, Sherlinski K, Ward SH. Prescription medication borrowing among adult patients at an urban medical center. J Urban Health 2011;88:997–1014.

Makowski CT, Gwinn KM, Hurren KM. Naltrexone/bupropion: an investigational combination for weight loss and maintenance. Obes Facts Eur J Obes 2011;4:489–94.

Hurren KM, Berlie HN. Lorcaserin: an investigational serotonin 2C agonist for weight loss. Am J Health Syst Pharm 2011;68:2029–37.

Pinelli NR, Hurren KM. Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared to exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Pharmacother 2011;45:850–60.

Mary Ann Kliethermes and Tim Brown are coeditors of a new ASHP book titled Building a Successful Ambulatory Practice: A Complete Guide for Pharmacists, and many of our members are authors of various chapters:

• Chapter 1: Defining the Ambulatory Patient Care Model; Edward P. Sheridan, Jeannie Kim Lee
• Chapter 2: Planning and Steps to Building the Ambulatory Practice Model; Steven M. Riddle, Jeffrey M. Brewer
• Chapter 3: Developing a Business Plan for an Ambulatory Practice; Kelly Epplen, Paul W. Bush
• Chapter 4: Marketing Your Ambulatory Practice; Mary Ann Kliethermes, Tim R. Brown, Tara L. Jenkins, Kevin Charles Farmer
• Chapter 5: Creating the Ambulatory Patient Care Model; Gloria P. Sachdev, Michelle L. Cudnik
• Chapter 6: Communication and Documentation for an Ambulatory Practice; Seena L. Haines, Tim R. Brown
• Chapter 7: Quality Assurance for Ambulatory Patient Care; Mary Ann Kliethermes
• Chapter 8: Reimbursement for the Pharmacist in an Ambulatory Practice; Sandra Leal, Betsy Bryant Shilliday, Amy L. Stump
• Chapter 9: Maximizing Your Ambulatory Practice: Planning for the Future; Stuart T. Haines, Jill S. Borchert

Bourg CA, Phillips BB. Rosiglitazone, myocardial ischemic risk, and recent regulatory actions. Ann Pharmacother 2012;46:282–90.

Goldman-Levine J. Beyond metformin: initiating combination therapy in patients with type 2 diabetes mellitus. Pharmacotherapy 2011;31(12 pt 2):44S–53S.

Kiser K, Jonas D, Warner Z, Scanlon K, Bryant Shilliday B, Dewalt D. A randomized controlled trial of a literacy-sensitive self-management intervention for chronic obstructive pulmonary disease patients. J Gen Intern Med 2011;27:190–5.

McBane S, Trewet CB, Nadra Havican S, Kiser K, Klingel C, Riche DM, Sease JM, Nau DP, Zillich AJ. Tenets for developing quality measures for ambulatory clinical pharmacy services. Pharmacotherapy 2011;31:115e–134e.

Klug C, Bonin K, Bultemeier N, Rozenfeld Y, Vasquez RS, Johnson M, Cherry JC. Integrating telehealth technology into a clinical pharmacy telephonic diabetes management program. J Diabetes Sci Technol 2011;5:1238–45.

Specialty Boards and Certifications:
Fall 2011 was the first year the Board of Pharmacy Specialties offered specialty certification in Ambulatory Care. Of the 518 pharmacists who passed the examination, more than 50% were members of the Ambulatory Care PRN! See the February 2012 issue of ACCP Report for a list of those members.

Maria Tzefos recently obtained her CDE.

Melody Hartzler recently became a certified asthma educator (AE-C).

Stephanie Nigro obtained her BC-ADM (Board Certified Advanced Diabetes Management).

Other Notable Achievements:
Henry Bussey retired from the University of Texas in August 2011 and is continuing his efforts in the development of ClotCare.org, the ClotFree system for online automated remote monitoring and management of anticoagulation, and in the development of the Genesis Clinical Research Center.

CoraLynn B. Trewet now sits on the NHLBI National Program to Reduce Cardiovascular Risk (NPRCR) Coordinating Committee. She is a representative for APhA and the only pharmacy representative on the committee.

Kelly Rudd has been chosen to serve on the Community Advisory Panel of ACCP’s Research Institute. She also became a member of the New York Anticoagulation Coalition and the Medicare Quality Improvement organization for New York State (IPRO). She also presented a poster at The International Rural Nursing and Rural Health Conference titled “Interdisciplinary Safety and Outcomes in the Rural Setting.”

Candice Lagasse was recently accepted into CMS’s Innovation Advisors Program. She is one of 73 individuals from 27 states and the only pharmacist selected.

Christina Madison was elected as president-elect of the Nevada Public Health Association.

Robin Koffarnus was named as the director of pharmacy services at the Montgomery Family Medicine Residency Program in Montgomery, Alabama.

Jennifer Goldman-Levine provided a talk at the recent 2011 ASHP Midyear Clinical Meeting & Exhibition titled “Creative Techniques to Engage Your Audience in Active Learning.”

Katie Kiser is the current president of the local chapter of ACCP – The District of Columbia College of Clinical Pharmacy.

The Cardiology PRN is pleased to report on several ongoing and new initiatives this year:

Congratulations to Sheryl Chow and Robert Page for their continued success with collaborative programming with the American Heart Association for the Scientific Sessions 2012 meeting in November 2012! This year, two program proposals were accepted, including the second annual pharmacist-focused session titled “Prevention and Management of Drug-Induced Cardiovascular Diseases,” developed by the Cardiology PRN and AHA Clinical Pharmacology Committee.

The Cardiology PRN Programming Committee is excited to announce two collaborative programs with the American Society of Hypertension: one at the 2012 ACCP Annual Meeting and the other at the American Society of Hypertension 2013 Annual Scientific Meeting.

The Awards and Recognition Committee is soliciting nominations for the Distinguished Investigator Award, Service Award, Clinical Practice Award, and Paper of the Year. Please contact committee cochairs Zachary Stacy and Rob DiDomenico with nominations.

A Key Papers bibliography paper on management of stroke is in preparation jointly with the Central Nervous System PRN (Chair: Bill Baker).

A Key Papers bibliography paper on cardiac surgery is in preparation (Chair: Ian Hollis).

The Cardiology PRN Fundraising Committee is planning a social reception for all ACCP members at the 2012 ACCP Annual Meeting. Details to follow! (Chair: Douglas Jennings)

Individual Member Accomplishments:
Judy Cheng received the 2011 Research Mentor Award-Summer Undergraduate Research Fellowship Program awarded by Massachusetts College of Pharmacy and Health Sciences.

Christina Glasgow received her BCPS credentials and was accepted into the 2012 ASHP Pharmacy Leadership Institute Program. Donald W. Graff received a Level II Scientific and Technical Achievement Award for 2010 for his contributions to a body of work evaluating the cardiovascular effects of air pollution particulate matter. This honor was awarded in October 2011.

Julie Bartell received BCACP credentials.

Dave L. Dixon is now assistant professor, Department of Pharmacotherapy and Outcomes Science at Virginia Commonwealth University School of Pharmacy.

Pat Howard received the Rho Chi 2011 Award for Teaching Excellence, Alpha Rho Chapter University of Kansas School of Pharmacy. The Cleveland VA Medical Center and the SERIOUS Heart Failure Medication Reconciliation Clinic – run by Sherry LaForest, Adam Pugacz, and Julie Gee, NP – were awarded one of the ISMP Cheers awards for medication safety in December 2011 for their postdischarge follow-up clinic and their ability to identify and correct medication errors with this system.

Craig R. Lee was awarded the 2011 Junior Investigator Award by the Cardiology PRN, and was named an ACCP Fellow.

Jo Ellen Rodgers has been elected as a distinguished practitioner and fellow in the National Academies of Practice in the Pharmacy Academy. The National Academies of Practice is composed of 10 academies representing various areas of health care practice. Founded in 1981, the NAP’s central purpose is to advise public policy-makers on health care issues. Only 150 active distinguished practitioners may be elected to each academy.

Andrew J. Smith received the Rho Chi National Faculty Advisor of the year, and he was elected to the Rho Chi executive board as Region VI Councilor.

Barbara S. Wiggins is now a pharmacy specialist-cardiology in the Department of Pharmacy Services at Medical University of South Carolina and adjunct associate professor, South Carolina College of Pharmacy.

Publications (limited to 3):
Haas CE, Eckel S, Arif S, et al. Acute care clinical pharmacy practice: unit- versus service-based models. Pharmacotherapy 2012;32:e35–e44.

Arif S, Poon H. Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension. Clin Ther 2011;33:993–1004.

Maxwell CB, Jenkins AT. Drug-induced heart failure. Am J Health Syst Pharm 2011;68:1791–804.

DiDomenico RJ. Fibrinolytics. In: Wiggins B, Sanoski S, eds. Emergency Cardiovascular Pharmacotherapy: A Point-of-Care Guide. Bethesda, MD: American Society of Health-System Pharmacists, 2012:chap 6.

Chow SL, Singh H, DiDomenico RJ, Dunn SP, Johnson SG, Marrs JC, Vardeny O, Bleske BE. Key articles related to complementary and alternative medicine in cardiovascular disease. Part 2. Pharmacotherapy 2011;31:208e–277e.

Ensor CR, Trofe-Clark J, Gabardi S, McDevitt-Potter LM, Shullo MA. Generic maintenance immunosuppression in solid organ transplant recipients. Pharmacotherapy 2011;31:1111–29.

Ensor CR, Doligalski CT. Antibody mediated rejection of the cardiac allograft. In: Moffatt-Bruce S, ed. Cardiac Transplantation. Rijeka, Croatia: InTech, 2012:23–40.

Finks SW, Airee A, Chow S, Macaulay TE, Moranville MP, Rogers KC, Trujilio T. Key articles of dietary interventions that influence cardiovascular risk. Pharmacotherapy 2012 Feb 13. [Epub ahead of print]

Miller DF, Garcia D, Kreys T, Phan SV, Vandenberg A, Garrison KL. Evaluating the quality of performance of medication reconciliation on hospital admission. Hosp Pharm 2012. In press.

You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(suppl):e531S–e575S.

Crouch MA, Colucci VJ, Howard PA, Spinler SA. P2Y12 receptor inhibitors: integrating ticagrelor into the management of acute coronary syndrome. Ann Pharmacother 2011;45:1151–6.

Lee CR, Bass A, Ellis K, Tran B, Steele S, Caughey M, Stouffer GA, Hinderliter AL. Relation between digital peripheral arterial tonometry and brachial artery ultrasound measures of vascular function in patients with coronary artery disease and in healthy volunteers. Am J Cardiol 2012;109:651–7.

Miller AE, Montague D, Rodgers JE, Sanghvi S, Whinna HC, Krumnacher H. Substitution of a heparin correlation value for activated partial thromboplastin time in heparin nomograms. Am J Health Syst Pharm 2011;68:893–8.

Tisdale JE, Overholser BR, Sowinski KM, Wroblewski HA, Amankwa K, Borzak S, Coram R, Kingery J, Zipes DM, Flockhart DA, Kovacs RJ. Enhanced sensitivity to drug-induced QT interval lengthening in patients with heart failure due to left ventricular systolic dysfunction. J Clin Pharmacol 2011 Nov 1. [Epub ahead of print]

Tisdale JE, Wroblewski HA, Kingery JR, Overholser BR, Trujillo TN, Kovacs RJ. Prospective, observational study of the prevalence of QT interval prolongation in patients admitted to cardiac care units in a large urban medical center and frequency of subsequent administration of QT interval-prolonging drugs. Drug Saf 2012. In press.

Tisdale JE. Review of cardiac arrhythmias and rhythm interpretation. In: Wiggins BS, Sanoski CA, eds. Emergency Cardiovascular Pharmacotherapy: A Point-of-Care Guide. Bethesda, MD: American Society of Health-System Pharmacists, 2012:13–48.

Vardeny O Hermanson MP, Andrei A, Detry MA, Stein JH. Differential effects of carvedilol and metoprolol on glycemic and lipid variables in hypertension are influenced by β-AR polymorphisms. Am J Hypertens 2012. In press.

Vardeny O, Pouleur AC, Takeuchi M, Appelbaum E, Verma A, Prescott MF, Smith B, Dahlof B, Solomon SD. Influence of diabetes on left ventricular mass regression with aliskiren, losartan, or both. J Renin Angiotensin Aldosterone Syst 2012 Mar 13. [Epub ahead of print]

Wiggins BS, Sanoski CA, eds. Emergency Cardiovascular Care: A Point-of-Care Guide. Bethesda, MD: American Society of Health-System Pharmacists, 2012.

Wiggins BS. Therapeutic hypothermia. In: Wiggins BS, Sanoski CA, eds. Emergency Cardiovascular Pharmacotherapy: A Point-of-Care Guide. Bethesda, MD: American Society of Health-System Pharmacists, 2012.

Zaiken K, Cheng JWM. Azilsartan medoxomil: a new angiotensin receptor blocker. Clin Ther 2011;33:1577–89.

Grants:
Mayo Clinic and partners to explore new ways to predict and control seizures Name: Jim Cloyd, Pharm.D.

The grant awards $1.5 million a year for up to 5 years. The principal investigators of the studies are Greg Worrell, M.D., Ph.D., Mayo Clinic; Ned Patterson, DVM, Ph.D., University of Minnesota College of Veterinary Medicine; Jim Cloyd, Pharm.D., University of Minnesota College of Pharmacy; Charles Vite, DVM, Ph.D., University of Pennsylvania School of Veterinary Medicine; Brian Litt, M.D., Perelman School of Medicine at the University of Pennsylvania; and Kent Leyde, the chief technology officer of NeuroVista Corporation of Seattle, Washington.

New ACCP Fellows:
Collin A. Hovinga, Pharm.D., M.S., Dell Children’s Medical Center-PSS/UT Austin, 1301 Barbara Jordan Boulevard, Suite 200, Austin, TX 78723-3078

Kelly C. Lee, Pharm.D., BCPP, UCSD Skaggs School of Pharmacy, 9500 Gilman Drive, MC 0719, La Jolla, CA 92093-0001

The Clinical Administration PRN has been actively pursuing a list of endeavors for 2012. The Programming/Focus Session Committee is working with the Industry PRN to address one of the main concerns voiced by members in our most recent survey. The program is titled “Effective Communication of the Value of Clinical Pharmacy Services.” The Research and Scholarship Committee plans to complete grant instructions and an application for PRN members to be available in the coming months. A committee is working on an outline for a PRN opinion paper. A rough draft is expected sometime this summer.

Students are requesting a more active role in the PRN. The PRN has initiated a PRN Student Liaison Committee. At this time, the committee members are working closely with the ACCP StuNet Advisory Committee (SNAC) to highlight each of the PRNs to students. The PRN is working on an application for students to apply to the PRN for a travel award to attend the ACCP Annual Meeting. Much growth is anticipated in student participation in the near future.

The PRN has teamed with the Geriatrics PRN to inform and educate AARP members regarding the role pharmacists and the profession can play in helping AARP members lead healthy lives. Articles from our PRN in AARP-related publications are anticipated in the near future.

The PRN has renewed dialogue with the Leadership Academy and is actively engaged in seeking topics, editors, and names of potential speakers for the Academy Newsletter and Certificate Program.

Notable Achievements:
Christopher K. Finch, Pharm.D., FCCM, BCPS, assistant director, Clinical Pharmacy Services, at Methodist University Hospital and associate professor at the University of Tennessee College of Pharmacy was recently recognized as a Fellow of the American College of Critical Care Medicine.

Roy Guharoy, Pharm.D., the chief pharmacy officer and a professor of medicine, University of Massachusetts Health Care, together with Robert W. Finberg, M.D., and Richard Haidack, a professor and chair, Department of Medicine, University of Massachusetts Medical School, recently wrote the book titled Clinical Use of Anti-infective Agents: A Guide on How to Prescribe Drugs Used to Treat Infections.

Mary E. Temple, Pharm.D., M.S., BCPS, a clinical specialist, Neonatology, Pediatrics and Maternal Medicine, and the director of the PGY1 Pharmacy Residency, Hillcrest Hospital – Cleveland Clinic, recently graduated with a B.S. degree in pharmaceutical outcomes and research with a specialization in institutional pharmacy leadership from the University of Florida.

John Noviasky, Pharm.D., BCPS, clinical coordinator, Upstate University Hospital at CGH, Syracuse, New York, received approval for an FDA grant for his project titled “Impact of Prescriber Education on Prescribing Patterns for Quetiapine.”

Congratulations to SCCM members of the PRN–Special Awards:

Judith Jacobi, Pharm.D., FCCM, FCCP, BCPS, was awarded the Society of Critical Medicine’s (SCCM) Distinguished Service Award. The award recognizes SCCM members who have made exceptional leadership contributions that have furthered the vision and mission of SCCM.

Sandra L. Kane-Gill, Pharm.D., M.S., FCCM, FCCP, accepted the Excellence in Using Technology to Improve ICU Medication Safety Award given by the Clinical Pharmacy and Pharmacology (CPP) Specialty Section of SCCM for a project titled “Human-Patient Simulator” (SimMan, Laerdal Medical). Additional awardees for this project were Daniel G. Ford, Pharm.D.; Amy L. Seybert, Pharm.D.; Pamela L. Smithburger, Pharm.D.; Lawrence R. Kobulinsky; and Joseph T. Samosky, Ph.D.

Mitchell S. Buckley, Pharm.D., FCCM, BCPS, accepted the Innovations in ICU Medication Safety Award given by the CPP Specialty Section of SCCM for a project titled “Impact of a Pharmacist-Conducted Admission Medication Reconciliation Program on Unintended Medication Discrepancies.” Additional awardees for this project were Craig A. Wesley, Pharm.D.; Butch David, R.Ph.; Earnest Alexander, Pharm.D., FCCM; Pamela L. Smithburger, Pharm.D., BCPS; Sandra L. Kane-Gill, Pharm.D., FCCM, FCCP; Lisa Harinstein, Pharm.D., BCPS; Kimberly Clark, Pharm.D., BCPS; and Sandeep Devabhakthuni, Pharm.D., BCPS.

Congratulations to New ACCM Fellows
Eight ACCP Critical Care PRN members were recently inducted as fellows of the American College of Critical Care Medicine. This distinction is granted to less than one-half of those who apply and signifies the individual’s “outstanding contributions to the collaborative field of critical care.” Members who were inducted in 2012 include Amy L. Dzierba, Pharm.D., BCPS; Christopher K. Finch, Pharm.D.; Lisa Hall Zimmerman, Pharm.D.; Thomas J. Johnson, Pharm.D., MBA, BCPS; Ishaq Lat, Pharm.D., BCPS; Eric W. Mueller, Pharm.D., R.Ph.; Catherine A. Pierce, Pharm.D.; and G. Christopher Wood, Pharm.D.

Promotions:
A. Shaun Rowe: Accepted a new position as an assistant professor, The University of Tennessee College of Pharmacy, Department of Clinical Pharmacy

Awards:
A. Shaun Rowe: Neurocritical Care Society Travel Award

Darla Eastman: Rho Chi Appreciation Award, 2012

Nicole M. Acquisto: 2011 Researcher of the Year, ACCP New York State Chapter

Publications:
Wall GC, Schirmer LL, Anliker LE, Tigges AE. Pharmacotherapy for pouchitis. Ann Pharmacother 2011;45:1127–37.

Koenigsfeld CF, Wall GC, Miesner AR, Schmidt G, Haack SL, Eastman DK, Grady S, Fornoff A. A faculty-led mock residency interview exercise for fourth-year doctor of pharmacy students. J Pharm Pract 2012 Feb 2. [Epub ahead of print]

Marr A. Mertense R, Eastman DK. Reactive arthritis induced by recurrent Clostridium difficile colitis. Rheumatol Rep 2012;4:e1–e3.

Grim SA, Berger K, Teng C, et al. Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes. J Antimicrob Chemother 2012;67:707–14.

Bentley ML, Tolwani AF. Acute and chronic renal failure and management. In: Roberson PR, Todd SR, eds. Society of Critical Care Medicine. Comprehensive Critical Care: Adult. Mount Prospect, IL: Society of Critical Care Medicine, 2012:chap 31.

Anliker LE, Kiser TK, Fish DN, MacLaren R, Sherman D, Neumann R, Mueller S. Evaluation of vancomycin and cefepime pharmacokinetics in critically ill neurosurgical patients. Crit Care Med 2011;39:abstract 694.

Anliker LE, Kiser TK, Fish DN, MacLaren R. Pharmacokinetic analysis of medication clearance for critically ill patients receiving continuous renal replacement therapy. Crit Care Med 2011;39:abstract 737.

Berger K, Johnson MT, Micek S. Effect of previous exposure to fluoroquinolones on cross resistance and gram negative sepsis mortality. Crit Care Med 2011;39:abstract 109.

Critical Care PRN Committee Activities:

Communications Committee – Scott Bolesta, Pharm.D., BCPS (Chair)
Although the Communications Committee is currently addressing its ongoing charges of updating the PRN History Document, coordinating the dissemination of PRN communications, and reviewing and updating the PRN Guidelines, its largest effort this year will be resurrecting the Critical Care PRN Newsletter. It has been almost 12 years since the Critical Care PRN published a newsletter. The newsletter will be used to keep PRN members abreast of ongoing activities within the PRN and ACCP between the biannual PRN Reports and ACCP meetings. Look for the first issue of the 2012 Critical Care PRN Newsletter to be distributed sometime in midsummer.

Recognition Committee – Christopher Paciullo, Pharm.D., BCPS (Chair)
The Recognition Committee has been busy facilitating the nomination of PRN members for the ACCP Education Award, Russell R Miller Award, and Clinical Practice Award. In addition, the committee has worked on nominating newer members for the ACCP New Clinical Practitioner, New Educator, and New Investigator awards. Please look for the annual Recognition Survey e-mail. This survey will attempt to capture all the accomplishments, awards, and outside recognition received by PRN members in the past year. In addition, the Recognition Committee will be responsible for coordinating the annual PRN awards. Please start thinking about the PRN member colleagues whom you might want to nominate for the Clinical Practitioner Award and Research Award.

Student, Resident, Fellow Committee – Pamela L. Smithburger, Pharm.D., BCPS (Chair)
The Critical Care PRN Student/Resident/Fellow Committee has developed and maintained a “Guide to PRN,” which summarizes fundamental principles about the Critical Care PRN, including leadership, opportunities for committee work, current trainee representation, activities, and awards. The Critical Care PRN Student/Resident/Fellow Committee also organizes the dissemination of an offer for complimentary PRN membership to all critical care residents and fellows. The “Guide to PRN” was included as part of the initial e-mail (and reminder e-mail) sent to program directors regarding the complimentary membership in April 2011.

Travel Award Committee – Michael L Bentley, Pharm.D. (Chair), Darla Eastman, Pharm.D., BCPS (Cochair), Nicole Acquisto Lynn Anliker Karen Berger, Elizabeth Farrington, Kellie Fortier, Rob MacLaren, Karea Petros, Bill Reed, Shaun Rowe

Committee’s Activities – The Travel Award Committee oversees two awards. Each is generally awarded to one individual to help support the costs of travel and attendance at the ACCP Annual Meeting. A call for abstracts will be sent to PRN members in August for the 2012 ACCP Annual Meeting. The winner is chosen on the basis of general abstract grading criteria (i.e., points awarded for introduction, hypothesis, methods, results, and conclusion). The amount of each award may vary, depending on funding, but it has been $1250.00 in recent years. Following are additional details regarding these awards.

Resident and Fellow Travel Award: The Critical Care PRN will award one travel grant per year to partly support the costs of travel and attendance of critical care fellows or residents at the ACCP Annual Meeting. To be eligible to apply, the candidate must meet the following criteria:

• Be a current member of the Critical Care PRN.
• Be currently completing training, or has completed training within the past 6 months, in a critical care residency or fellowship program (under the direction of a Critical Care PRN member) or a PGY1 residency.
• Have an abstract accepted for presentation at the ACCP Annual Meeting. For applicants who have completed training within the past 6 months, the research being presented must have been a project completed during their residency or fellowship training.

Young Investigator Travel Award: The Critical Care PRN will award one travel grant per year to partly support the costs of travel and attendance of a young investigator at the ACCP Annual Meeting. To be eligible to apply, the candidate must meet the following criteria:

• Be a current member of the Critical Care PRN
• Have completed training within the past 3 years
• Have an abstract accepted for presentation at the ACCP Annual Meeting

For each award, the recipient will be required to present his or her work as a platform presentation of no more than 10 minutes at the Critical Care PRN networking and business meeting at the ACCP Annual Meeting.

Promotions:
Julie P. Karpinski, Pharm.D., BCPS: Promotion to an associate professor and a pharmacy practice director, Drug Information, Concordia University School of Pharmacy

Dr. Dennis F. Thompson has been named the dean of the College of Pharmacy at Southwestern Oklahoma State University in Weatherford.

Grants:
Ward KE, Szumita LB. “Promoting Safe Use of Medications by Providing Medication Education to Seniors Receiving Meals on Wheels.” Granting agency: FDA; award amount: $38,000

Publications:
Rosselli JL, Thacker SM, Karpinski JP, Petkewicz KA. Treatment of IgA nephropathy: an update. Ann Pharmacother 2011;45:1284–96.

Karpinski JP. Medication expiration and beyond use dating. Drug Store News Continuing Education. Pharmacy Tech News CE Lesson, Summer 2011

Kier K, Goldwire MA. Drug information resources and literature retrieval. In: Pharmacotherapy Self-Assessment Program. Lenexa, KS: American College of Clinical Pharmacy, 2011.

Labdi BA. What drug is this? In: Zlatic TD, Zellmer WA, eds. Nourishing the Soul of Pharmacy: Stories of Reflection. Lenexa, KS: ACCP, 2011.

Labdi BA. Brentuximab vedotin in the treatment of CD30-positive lymphomas. HOPA News 2012;9.

Other Notable Achievements:
Sandra Harley Counts, Pharm.D., Editorial Board for DynaMed Point of Care Database, part-time medical writer for DynaMed reviews; faculty at AnMed Health Family Medicine Residency Program

Labdi BA. Paradigm shift in VTE prophylaxis after knee and hip replacement surgery. Paper presented at: Virginia Society of Health System Pharmacists annual meeting; October 28, 2011; Norfolk, VA.

Fox ER, Pharm.D., received an ISMP Cheers award. Dr. Fox directs the University of Utah Drug Information Service, which provides shortage information on ASHP’s Web site to keep the health care community up-to-date.

The Education and Training PRN membership has grown to more than 380 members who are advancing the PRN’s mission. Our goal is to promote dialogue and interaction to develop programs that enhance the knowledge and skills needed to provide education and training within clinical pharmacy. The PRN and its members are proud to share our many accomplishments during the past several months, and they anticipate a busy year for 2012–2013.

Our Scholarly Activities Committee published a paper in the November 2011 issue of the American Journal of Pharmaceutical Education on implementing active learning in U.S. schools of pharmacy curricula. The committee is planning the development of a book that will offer useful teaching tips for clinical faculty and preceptors. A special thanks to Tina Denetclaw for her leadership on this very active committee.

At the upcoming ACCP Spring Updates in Therapeutics^® meeting in Reno, Nevada, the EDTR PRN will host a networking breakfast on Monday, April 30, at 7:30 a.m. Mark your calendars to attend—this will be a good opportunity to meet other PRN members and exchange ideas about teaching and learning.

The EDTR PRN will host mock interviews again this year for students, residents, and fellows during its business meeting at the 2012 Annual Meeting in October. We welcome interviewees (students, residents, and fellows) as well as interviewers. You need not be a member of the PRN to participate. Be watching for additional details through the PRN e-mail list in September 2012. In the meantime, please contact Haley Phillippe ([email protected]) or Kristi Kelley ([email protected]) for additional information. Feel free to share this information with colleagues at your respective institutions.

The EDTR is growing and would like to continue expanding its membership! We encourage ACCP members who are interested improving clinical pharmacy education and training to join the EDTR PRN.

EDTR PRN Member Achievements Promotions:
Amy Tiemeier, Pharm.D., BCPS: Dr. Tiemeier has accepted a new position at the St. Louis College of Pharmacy. She will become the director of professional affairs for the college.

Lamis R. Karaoui, Pharm.D., BCPS: Dr. Karaoui was recently appointed as the director of experiential education – School of Pharmacy, Lebanese American University.

Heather P. Whitley, Pharm.D., BCPS, CDE: Dr. Whitley will be promoted to an associate clinical professor at Auburn in the fall.

Awards:
Christina M. Madison, Pharm.D., BCACP: One to One Counseling Award from Pharmacy Today Magazine and the American Pharmacist Association (APhA), receiving an honorable mention. Dr. Madison was one of 20 pharmacists in the country to receive this award (March 10, 2012, in New Orleans, Louisiana). Achieved board certification—Board Certified Ambulatory Care Pharmacy (BCACP)

Grants – Extramural Funding:
Heather P. Whitley, Pharm.D., BCPS, CDE
Whitley HP. “Diagnosing Diabetes in a Rural Alabama Family Medicine Practice.” Principal investigator; 2012–2013: Diabetes Hand Foundation. $10,000 on August 5, 2011.
Status: funded

Foster J, Whitley HP, Berns C, Thomas C. “Capstone Rural Health Center patient safety and clinical pharmacy collaborative.” Coinvestigator; 2011: Project IMPACT: Diabetes Community. American Pharmacists Association Foundation. $25,000 on March 8, 2011.
Status: funded

Publications:
Brenda L. Gleason, Pharm.D.; Michael J. Peeters, Pharm.D., MEd, BCPS; Beth H. Resman-Targoff, Pharm.D., FCCP; Samantha Karr, Pharm.D., BCPS, BCACP; Sarah McBane, Pharm.D., BCPS, CDE; Kristi Kelley, Pharm.D., BCPS, CDE; Tyan Thomas, Pharm.D.; and Tina H. Denetclaw, Pharm.D., BCPS Gleason BL, Peeters MJ, Resman-Targoff BH, Karr S, McBane S, Kelley K, Thomas T, Denetclaw TH. An active-learning strategies primer for achieving ability-based educational outcomes. Am J Pharm Educ 2011;75:Article 186.

Tyan Thomas, Pharm.D.; Samantha Karr, Pharm.D., BCPS, BCACP; Kristi Kelley, Pharm.D., BCPS, CDE; and Sarah McBane, Pharm.D., BCPS, CDE Thomas T, Karr S, Kelley KW, McBane S. Overcoming barriers to scholarly activity in a clinical practice setting. Am J Health Syst Pharm 2012;69:465–7.

Heather P. Whitley, Pharm.D., BCPS, CDE
Whitley HP. Monetary value of a prescription assistance program service in a rural family medicine clinic. J Rural Health 2011;27:190–5.

Presentations:
Heather P. Whitley, Pharm.D., BCPS, CDE

Whitley HP. Obesity in Alabama. Presented at: Tuscaloosa Dietetic Association; January 2012; CPE Level II; Tuscaloosa, AL.

Whitley HP. Choosing incretin products for treating diabetes mellitus. Presented at: Summer New Consultant Update and Therapeutic Conference, Auburn University Harrison School of Pharmacy; July 2011; Auburn, AL.

Whitley HP. A medley of diabetes topics. Presented at: Alabama Pharmacy Association 128th Annual Convention & Trade Show; June 2011; Sandestin, FL.

Whitley HP. Alabama Obesity Task Force update. Presented at: Boshell Diabetes and Metabolic Disease Research Day, Auburn University; March 2011; Auburn, AL.

Lamis R. Karaoui, Pharm.D., BCPS
Karaoui LR. Implementation of and experience with a locally developed summative exit exam delivered to Pharm.D. students before graduation. Presented at: ACCP Annual Meeting; October 2011.

Leadership:
Heather P. Whitley, Pharm.D., BCPS, CDE
Southeastern Diabetes Education Services, Board member – February 2012 to present
Alabama State Obesity Task Force, Alabama Department of Public Health; Chair – February 2011–2012

Christina M. Madison, Pharm.D., BCACP
Dr. Madison was elected as president-elect of the Nevada Public Health Association (NPHA) for 2012, and she will serve as president in 2013.

Other Notable Accomplishments:
Heather P. Whitley, Pharm.D., BCPS, CDE

Appearance in two international videos:
Big Blue Test 2011: Moundville Medical Clinic near Tuscaloosa, AL, documentary. Filmed in Tuscaloosa, Alabama, on October 11, 2011. Released at www.youtube.com/watch?v=ZXhAjsqLV9U and http://bigbluetest.org/ on November 8, 2011. Sponsored by the Diabetes Hands Foundation
Do the Big Blue Test: Help Yourself, Help Others, Big Blue Test, World Diabetes Day 2011 promotional Internet video featured specialist. Filmed in Tuscaloosa, Alabama, on October 11, 2011. Released at www.youtube.com/watch?v=mSeA7f1iYlQ and http://bigbluetest.org/ on November 1, 2011. Sponsored by the Diabetes Hands Foundation

Current Officers:
Chair: Kevin O. Rynn, Pharm.D., FCCP, DABAT
Chair-Elect: Nicole M. Acquisto, Pharm.D., BCPS
Secretary/Treasurer: Asad (Sid) Patanwala, Pharm.D., BCPS
Media Chair: Wichitah P. Leng, Pharm.D.

Please stop by the Emergency Medicine PRN (EMED PRN) table at the ACCP networking breakfast on Sunday, April 29, 2012, from 7:30 a.m. to 9:00 a.m. at the Peppermill Resort, Reno, Nevada, as part of the series of networking breakfasts during ACCP’s 2012 Updates in Therapeutics^®.

The EMED PRN would like to acknowledge and congratulate all of its members on their accomplishments and achievements:

Awards:
Nicole M. Acquisto, Pharm.D., BCPS: New York State Chapter of ACCP – Research of the Year 2011

Eric H. Gilliam, Pharm.D., BCPS: Hawaii Pharmacists Association’s 2011 Innovative Pharmacy Practice Award in recognition of starting the ED pharmacy program at his institution

Stephanie Weightman, Pharm.D., BCPS, together with Children’s Medical Center, Dallas, TX: APhA’s 2011 Immunization Champion Award in recognition of an EM pharmacist-led multidisciplinary collaboration to increase the use of an in-house program that provides influenza vaccines at no charge to household contacts of patients, with more than 340 influenza vaccines administered in the ED to household contacts, 90% of which are provided by EM pharmacists and pharmacy interns

Presentations:
Megan Musselman, Pharm.D., BCPS, and Suprat Saely, Pharm.D., BCPS:

Saely S, Musselman ME, Bora KM. Case series of severe calcium channel blocker toxicity treated with high concentration infusion of high dose insulin. Clin Toxicol 2011;49:593. Presented at: Annual Meeting of the North American Congress of Clinical Toxicology; September 2011; Washington, DC.

Musselman ME, Saely S, Faris PJ, Browning LA, Sherwin RL, Zimmerman LH. Does etomidate dosing for rapid sequence intubation impact hemodynamics? Ann Emerg Med 2011;58:S282. Presented at: American College of Emergency Physicians (ACEP); October 2011; San Francisco, CA.

Musselman ME, Smolinske S, Aaron C, Farber M, Saely S. A comparison of high-dose insulin therapy and conventional inotropic therapy in calcium channel blocker and/or β-blocker toxic ingestions. Ann Emerg Med 2011;58:S325. Presented at: ACEP; October 2011; San Francisco, CA.

Kevin O. Rynn, Pharm.D., FCCP, DABAT:
Cocchio C, Geib AJ, Rynn KO. Physiochemical stability of intravenous fat emulsion in combination with medications used during resuscitation. Paper presented at: 2011 Annual Meeting of the North American Congress of Clinical Toxicology; September 2011; Washington, DC.

Michener L, Hanes S, Abel M, Rosenkranz J, Rynn K, Garber S, Mamidi S, Meredith G. ICLB: a team-based curricular integration project. Paper presented at: American Association of Colleges of Pharmacy Annual Conference; July 2011; San Antonio, TX; and Illinois Pharmacist Association Annual Conference; September 2011; Springfield, IL.

Michael C. Thomas, Pharm.D., BCPS:
Weant KA (Program Chair/Moderator), Thomas MC (New windows, same old house), Weant KA (If you can’t go in reverse, you better have a good map to follow). Meeting the challenges of acute stroke management in the emergency department. Activity No. 204-000-11-214-LO1P. Presented at: ASHP Midyear Clinical Meeting & Exhibition; December 5, 2011; New Orleans, LA.

Draper-Eppert H (Moderator), Thomas MC (Updates in basic life support and pulseless algorithms), Witsil J (Symptomatic arrhythmias and post-cardiac arrest care in adults for 2010 ACLS), Manzi S (PALS updates-2010 guidelines). Do you know your new alphabet – updates in the ACLS and PALS guidelines. Presented at: Live Webinar; American Society of Health-System Pharmacists; May 18, 2011.

Ott CA (Moderator and Psychiatric Disorders Speaker), Thomas MC (Emergency Medicine Speaker). Psychiatric disorders and emergency medicine. Activity No. 0217-0000-11-025-L01-P (3 hours). Presented at: Updates in Therapeutics^®: The Ambulatory Care Pharmacy Preparatory Review Course. ACCP 2011 Updates in Therapeutics^® meeting; April 10, 2011; Columbus, OH.[Scheduled to speak again in May 2012]

Publications:
Nicole M. Acquisto, Pharm.D., BCPS:
Patanwala AE, Sanders AB, Thomas MC, Acquisto NM, Weant KA, Baker SN, Merritt EM, Erstad BL. A prospective multicenter study of the methods of medication error interception by emergency department pharmacists. Ann Emerg Med. In press.

Baker S, Acquisto NM, Dodds Ashley E. Evaluation of emergency pharmacist services on antimicrobial stewardship for ambulatory patients discharged from the emergency department. J Pharm Pract. In press.

Morse B, DiCenzo R, Baciewicz G, Tessena M, Acquisto NM, Hutchinson D, Morris M. Monocarboxylate transporter inhibition with osmotic diuresis increases gamma-hydroxybutyrate renal elimination in humans: a proof-of-concept study. J Clin Toxicol 2011;1:2.

Thomas MC, Acquisto NM, Patanwala AE, Weant KA, Baker SN. Key articles and guidelines for the emergency medicine pharmacist. Pharmacotherapy 2011;31:454e–491e.

Paul T. Green, Pharm.D., BCPS:
Kupas DF, Shayhorn MA, Green PT, Payton TF. Structured inspection of medications carried and stored by emergency medical services agencies identifies practices that may lead to medication errors. Prehosp Emerg Care 2012;16:67–75.

Erica M. Merritt, Pharm.D.:
Patanwala AE, Sanders AB, Thomas MC, Acquisto NM, Weant KA, Baker SN, Merritt EM, Erstad BL. A prospective multicenter study of the methods of medication error interception by emergency department pharmacists. Ann Emerg Med. In press.

Megan Musselman, Pharm.D., BCPS, and Suprat Saely, Pharm.D., BCPS:
Musselman ME, Browning LA, Parker D Jr, Saely S. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome. Ann Pharmacother 2011;45:e61.

Asad (Sid) Patanwala, Pharm.D., BCPS:
Patanwala AE, Sanders AB, Thomas MC, Acquisto NM, Weant KA, Baker SN, Merritt EM, Erstad BL. A prospective multicenter study of the methods of medication error interception by emergency department pharmacists. Ann Emerg Med. In press.

Patanwala AE, Edwards CJ, Stolz L, Amini R, Desai A, Stolz U. Should morphine dosing be weight-based for analgesia in the emergency department? J Opioid Manag 2012;8:51–5.

Patanwala AE, Barletta JF, Erstad BL. Pharmacoepidemiology and patient safety in the critically ill. Pharm Policy Law 2012;14:93–104.

Baggs JH, Patanwala AE, Williams EM, Erstad BL. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal. Ann Pharmacother 2012;46:51–6.

Thomas MC, Jennett-Reznek AM, Patanwala AE. Combination of ketamine and propofol versus either agent alone for procedural sedation in the emergency department. Am J Health Syst Pharm 2011;68:2248–56.

Thomas MC, Acquisto NM, Patanwala AE, Weant KA, Baker SN. Key articles and guidelines for the emergency medicine pharmacist. Pharmacotherapy 2011;31:454e–491e.

Kevin O. Rynn, Pharm.D., FCCP, DABAT:
Rynn KO, Hughes FL. Toxicology. In: Wiggins BS, Sanoski CA, eds. Emergency Cardiovascular Pharmacotherapy. Bethesda, MD: American Society of Health-System Pharmacists, 2012:201–26.

Michael C. Thomas, Pharm.D., BCPS:
Thomas MC. The value of residency training and the 2020 initiative. In: Crouch MA, ed. Securing and Excelling in a Pharmacy Residency. Sudbury, MA: Jones & Bartlett Learning, 2011:chap 2.

Thomas MC. Emergency medicine. In: Bainbridge JL, Barbour SY, Coyle EA, et al, eds. Updates in Therapeutics^®: The Ambulatory Care Pharmacy Preparatory Review Course, 2011 ed. Lenexa, KS: American College of Clinical Pharmacy, 2011:1-459–1-498.

Patanwala AE, Sanders AB, Thomas MC, Acquisto NM, Weant KA, Baker SN, Merritt E, Erstad BL. A prospective, multicenter study of medication errors intercepted by emergency department pharmacists. Ann Emerg Med. In press.

Thomas MC, Acquisto NM, Patanwala AE, Weant KA, Baker SN. Key articles and guidelines for the emergency medicine pharmacist. Pharmacotherapy 2011;31:454e–491e. Available at www.pharmacotherapyjournal.org.

Thomas MC, Jennett-Reznek AM, Patanwala A. Combination of ketamine and propofol versus either agent alone for procedural sedation in the emergency department. Am J Health Syst Pharm 2011;68:2248–56.

Thomas MC, Shah S. New treatment options for acute edema attacks caused by hereditary angioedema. Am J Health Syst Pharm 2011;68:2129–38.

Kyle A. Weant, Pharm.D., BCPS:
Thomas MC, Acquisto NM, Patanwala AE, Weant KA, Baker SN. Key articles and guidelines for the emergency medicine pharmacist. Pharmacotherapy 2011;31:454e–491e.

2012 Emergency Medicine PRN Focus Session
The EMED PRN Educational Programming Committee is developing the fall 2012 focus session for the ACCP Annual Meeting in Hollywood, Florida, titled “Traumatic Emergencies: Blood, Brain, and Bacteria.” The goal of this session is to provide practitioners working in an acute care setting and involved in the care of trauma patients with updates in major drug therapy issues related to traumatic injury.

CODE Program
Looking to expand your current EM practice? Interested in forming a partnership in which you can share ideas to further your current pharmacy practice?

Look no further! The EMED PRN has created a new program – the Collaborative Organization for Development of Emergency Medicine Pharmacists (CODE Program) – to encourage idea sharing and foster professional growth by forming meaningful partnerships among EM pharmacists. The program will continuously match participants on the basis of personally identified strengths and goals, as indicated on the registration form.

To participate, simply complete the Participant Bio found on the EMED PRN homepage under PRN Documents/CODE Program Documents/Bio for CODE Program Participant and submit the form. All members are encouraged to join! We hope this will be a great tool for us to work together to advance our practice!

The EMED PRN would also like to recognize the following committee members and volunteers.

CODE Program Committee:
Nicole M. Acquisto, Pharm.D., BCPS
Samantha S. Bastow, Pharm.D.
Wichitah Leng, Pharm.D.
Asad (Sid) Patanwala, Pharm.D., BCPS
Melissa Rubel, Pharm.D.
Mary Beth Shirk, Pharm.D., BCPS
Kyle Weant, Pharm.D., BCPS

Educational Programming Committee:
Nicole M. Acquisto, Pharm.D., BCPS
Renee Petzel Gimbar, Pharm.D.
Kevin Kaucher, Pharm.D.
Asad (Sid) Patanwala, Pharm.D., BCPS
Stephen Rolfe, Pharm.D., BCPS
Mary Beth Shirk, Pharm.D., BCPS
Kyle Weant, Pharm.D., BCPS

Media Committee Members:
Christina Candeloro, Pharm.D., BCPS
Jill Jessmer, Pharm.D.
Wichitah Leng, Pharm.D.
Christina McKenzie
Katelin Speer, Pharm.D.

The Endocrine and Metabolism PRN is composed of members from a variety of practice settings. The PRN was formed to achieve the following goals and objectives. (1) Provide an opportunity for pharmacists with an interest in endocrine and metabolism disorders to promote practice, research, and education in these areas. (2) Provide a mechanism for members with similar interests to meet during ACCP meetings to network, problem solve, and discuss professional issues and opportunities. (3) Promote practice involvement; educational needs of health care professionals, students, and patients; and research activities in the areas of endocrinology and metabolism that may be favorably affected by this ACCP PRN effort.

During the past 6 months, some notable member accomplishments are as follows.

Promotions:
Candis Morello: Associate Dean for Student Affairs, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences

Grants:
Nicole Pinelli: “Effect of Liraglutide on Tacrolimus Pharmacokinetics in Renal Transplant Recipients.” Funded by: Wayne State University

Awards:
Kathryn Hurren: Pharmacist of the Year Award, Southeastern Michigan Society of Health-System Pharmacists

Publications:
Jennifer Goldman-Levine
Goldman-Levine JD. Beyond metformin: initiating combination therapy in patients with type 2 diabetes mellitus. Pharmacotherapy 2011;31:44S–53S.

Kathryn Hurren
Makowski CT, Gwinn KM, Hurren KM. Naltrexone/bupropion: an investigational combination for weight loss and maintenance. Obes Facts Eur J Obes 2011;4:489–94.

Hurren KM, Berlie HN. Lorcaserin: an investigational serotonin 2C agonist for weight loss. Am J Health Syst Pharm 2011;68:2029–37.

Pinelli NR, Hurren KM. Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared to exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Pharmacother 2011;45:850–60.

Candis Morello
Morello CM. Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus. Int J Gen Med 2011;4:827–35.

Ghafouri N, Hirsch JD, Heydari G, Morello CM, Kuo GM, Singh RF. Waterpipe smoking among health sciences university students in Iran: perceptions, practices and patterns of use. BMC Res Notes 2011;4:496.

Morello CM. Learning life’s lessons from unexpected places. In: Zlatic TD, Zellmer WA, eds. Nourishing the Soul of Pharmacy: Stories of Reflection. Lenexa, KS: American College of Clinical Pharmacy, 2011:25–6.

Nicole Pinelli
Pinelli NR, Jones MC, Monday LM, Smith Z, Rhoney DH. Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients. Ann Pharmacother 2012;46:124–9.

Pinelli NR, Jantz AS, Martin ET, Jaber LA. Sensitivity and specificity of glycated hemoglobin as a diagnostic test for diabetes and prediabetes in Arabs. J Clin Endocrinol Metab 2011;96:E1680–3.

Pinelli NR, Hurren KM. Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared to exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Pharmacother 2011;45:850–60.

Pinelli NR, Brown MB, Herman WH, Jaber LA. Family support is associated with success in achieving weight loss in a group lifestyle intervention for diabetes prevention in Arab-Americans. Ethn Dis 2011;21:480–4.

Presentations:
Jennifer Goldman-Levine: Creative techniques to engage your audience in active learning. Paper presented at: ASHP Midyear Clinical Meeting & Exhibition; December 2011.

Nicole Pinelli: New treatment options for the management of diabetes mellitus: focus on incretin-based therapies. Paper presented at: Detroit Medical Center 5th Annual Diabetes Symposium; October 2011; Detroit, MI.

The following members presented at the Endocrine PRN focus session at the ACCP Annual Meeting in October:
Nicole Pinelli: Emerging therapies in diabetes
Rick Hess: GLP-1 agents in metabolic syndrome/obesity
Marissa Quinones: Metformin use for chronic kidney disease patients
Kim Kelly: Glucose variability impact
Jessica Trompter: U-500: appropriate use and common pitfalls
Tricia Russell and Craig Logemann: ADA algorithm versus AACE algorithm for diabetes: a debate

Other Accomplishments:
Jennifer D’Souza and Christie Schumacher received BC-ADM certification.

Specialty Certification:
The Endocrine and Metabolism PRN would like to congratulate the following members who passed the specialty certification examination offered in October 2011 by the Board of Pharmacy Specialties in either pharmacotherapy or ambulatory care pharmacy.

Becky Armor – BCACP
Debra Barnette – BCACP
Jessica Bellone – BCACP
Jeffrey Cavanaugh – BCPS
L. Brian Cross – BCACP
Michelle Edwards – BCPS
Paul Erwin – BCACP
Kristin Franklin – BCACP
Chad Gentry – BCACP
Benjamin Gross – BCACP
Teresa Hoffmann – BCACP
Brian Irons – BCACP
Jeremy Johnson – BCACP
Michael Kane – BCACP
Samantha Karr – BCACP
Titilayo Kazeem – BCPS
Naureen Khan – BCACP
Daniel Kildow – BCACP
Mary Klein – BCACP
Erin Koepf – BCACP
Robin Koffarnus – BCACP
Debra Lopez – BCACP
Molly Minze – BCACP
Stephanie Nigro – BCACP
Lewis Till – BCACP
Ayla Tourkmani – BCPS
Andra Traina – BCACP

The Endocrine and Metabolism PRN has more than 220 members and represents a diverse group of clinical pharmacists dedicated to advancing clinical practice, teaching, and research. The Endocrine and Metabolism PRN would like to welcome the newest members of the group since September 2011:

Ahmad Alghamdi
Hope Barnes
Mary Butcher

Resident Travel Scholarship
The Endocrine and Metabolism PRN Residency Travel Scholarship is intended to provide financial support for a resident-level member to the annual or spring ACCP meeting. The applicant must be a resident member (PGY1 or PGY2) of the ACCP Endocrine and Metabolism PRN. The applicant must provide a statement of why he or she is involved with the Endocrine and Metabolism PRN and describe how attending the meeting will assist in the applicant’s career and/or residency goals. A current copy of the applicant’s CV, highlighting professional organizations and community service, together with one letter of recommendation are required for complete application.

Congratulations to Dr. Misty D. Gaddis, a PGY1 pharmacy practice resident at the Veteran Affairs Gulf Coast Joint Ambulatory Care Center, who will receive the ACCP Endocrine and Metabolism PRN Resident Scholarship. She will receive $500 to attend ACCP’s 2012 Updates in Therapeutics^® meeting in Reno, Nevada.

Biweekly Online Journal Club
The Communications Committee continues to lead the PRN in the biweekly online journal club on our PRN e-mail list. The online journal club was implemented in February 2010. The purpose of the online journal club is to provide an awareness of key articles that add new information to the fields of endocrinology and metabolism. Members of the PRN are periodically asked to contribute articles and comments to foster active discussion. Active members from the Communications Committee have been soliciting journal club articles from the PRN e-mail list and have been posting two articles every other week for active discussion through the PRN e-mail list. The following members have been involved in co ntinuing the biweekly online journal club: Nicole Pinelli (Communications Committee chair), Jessica Bellone (member), Amy Calabrese Donihi (member), Kathryn Hurren (member), Christie Schumacher (member), and Jessica Trompeter (member). Please contact Nicole Pinelli, [email protected], for more information about the online journal club.

The Geriatrics PRN is composed of clinical pharmacists dedicated to the care of older people as well as related issues involving aging. The PRN’s membership crosses a broad spectrum of interests, ranging from clinical practice to basic and clinical research. Practice settings also run the full spectrum of health care, including home health care, ambulatory care, nursing homes, and community, Veterans Administration, and university-affiliated sites. The PRN’s goals include providing programming on topics in geriatrics and aging that are of importance to its members and providing the opportunity for PRN members to network for purposes of sharing information and developing collaborative research. The following is an update of the professional involvement of Geriatrics PRN members.

Awards:
Zachary A. Marcum, Pharm.D., M.S., BCPS NIH Loan Repayment Award (07/11–06/13) Research selected for the Presidential Poster Section at the annual AGS meeting 2011

Grants:
Timothy Reilly, Pharm.D., FASCP, BCPS, CGP Rutgers Faculty Research Grant Program: “Avoiding Medication Errors in the Geriatric Population Through Pharmaceutical Intervention”

Publications:
Melissa Butler, Pharm.D.
Butler MG, Farley JF, Sleath BL, Murray MD, Maciejewski ML. Who looks for Medicare Part D information?: a focus on recognition of need and patient activation. Res Social Adm Pharm 2012 Jan 31. [Epub ahead of print]

Matthew Cantrell, Pharm.D., BCPS
Skoff RA, Waterbury NV, Shaw RF, Egge JA, Cantrell M. Glycemic control and hypoglycemia in Veterans Health Administration patients converted from glyburide to glipizide. J Manag Care Pharm 2011;17:664–71.

Cantrell MA, Bream-Rouwenhorst HR, Watts C, Oetting TA. Pathophysiology and pre-operative evaluation of patients at risk for intraoperative floppy iris syndrome (IFIS). In: Zaidi F, ed. Cataract Surgery/Book 2. Rijeka, Croatia: InTech, 2012.

Julie A. Fusco, Pharm.D., BCPS, CGP Fusco JA. Elder abuse. In: Richardson MM, Chessman KH, Chant C, et al, eds. Pharmacotherapy Self-Assessment Program, 7th ed. Geriatrics. Lenexa, KS: American College of Clinical Pharmacy, 2011:115–29.

Olga Hilas, Pharm.D., MPH, FASCP, BCPS, CGP
Hilas O, Ezzo D. Immunizations in the elderly. Pharmacotherapy Self-Assessment Program, 7th ed. Geriatrics. Lenexa, KS: American College of Clinical Pharmacy, 2011:195–207.

Hilas O. Management of gastroparesis. US Pharm 2011;36:HS15–HS18.

Hilas O, Avena-Woods C. Neurocardiogenic syncope: a focus on the management of vasovagal episodes. US Pharm 2011;36:HS2–HS11.

Zachary A. Marcum, Pharm.D., M.S., BCPS
Pugh MV, Starner CI, Amuan ME, Berlowitz DR, Horton M, Marcum ZA, Hanlon JT. Exposure to potentially harmful drug-disease interactions in older community-dwelling veterans based on the Healthcare Effectiveness Data and Information Set Quality Measure: who is at risk? J Am Geriatr Soc 2011;59:1673–8.

Marcum ZA, Perera S, Donohue JM, Boudreau RM, Newman AB, Ruby CM, Studenski SA, Kwoh CK, Simonsick EM, Bauer DC, Satterfield S, Hanlon JT. Analgesic use for knee and hip osteoarthritis in community-dwelling elders. Pain Med 2011;12:1628–36.

Marcum ZA, Amuan ME, Hanlon JT, Aspinall SL, Handler SM, Ruby CM, Pugh MV. Prevalence of unplanned hospitalizations caused by adverse drug reactions among older veterans. J Am Geriatr Soc 2012;60:34–41.

Marcum ZA, Pugh MV, Amuan ME, Aspinall SL, Handler SM, Ruby CM, Hanlon JT. Prevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans. J Gerontol A Biol Sci Med Sci 2012. In press.

Marcum ZA, Fried LF. Aging and anti-hypertensive medication related complications in the CKD patient. Curr Opin Nephrol Hypertens 2011;20:449–56.

Marcum ZA, Gellad WF. Medication adherence and polypharmacy. Clin Geriatr 2012. In press.

Marcum ZA, Peron EP, Hanlon JT. Medication Use in Older Adults. The Epidemiology of Aging. New York: Springer, 2012. In press.

Marcum ZA, Hanlon JT. Inappropriate medication use and medication errors in the elderly. In: Wehling M, Burkhardt H, eds. Drug Therapy in the Elderly, 2nd ed. New York: Springer-Verlag, 2012. In press.

Gellad WF, Good CB, Amuan ME, Marcum ZA, Hanlon JT, Pugh MV. Facility-level variation in potentially inappropriate prescribing for older veterans. J Am Geriatr Soc 2012. In press.

Marcum ZA, Amuan ME, Hanlon JT, Aspinall SL, Handler SM, Ruby CM, Pugh MV. Adverse drug reactions leading to hospitalization among older outpatient veterans. Poster presented at: American Geriatrics Society Annual Scientific Meeting, Presidential Poster Section; May 2011; Washington, DC.

Marcum ZA, Amuan ME, Hanlon JT, Aspinall SL, Handler SM, Ruby CM, Pugh MV. Therapeutic failures and adverse drug withdrawal events leading to hospitalization among older outpatient veterans. International Society for Pharmacoepidemiology International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011; Chicago, IL.

Marcum ZA, Rovesti KL, Behrens MC, Logsdon M, Aspinall SL, Francis S, Jeffrey S, Hanlon JT, Handler SM. Prevalence of adverse drug events across three VA community living centers. Paper presented at: American College of Clinical Pharmacy Annual Meeting; October 2011; Pittsburgh, PA.

Emily Peron, Pharm.D., FASCP, BCPS
Peron EP, Marcum ZA, Boyce R, Hanlon JT, Handler SM. Year in review: medication mishaps in the elderly. Am J Geriatr Pharmacother 2011;1:1–10.

Peron EP, Gray SL, Hanlon JT. Medication use and functional status decline in older adults: a narrative review. Am J Geriatr Pharmacother 2011;9:378–91.

Peron EP, Ruby CM. A primer on medication use in older adults for the non-clinician. Generations. Winter 2011–12.

Invited Presentations:
Wortmann R, Finn W, Hilas O. Gout, hyperuricemia, and chronic kidney disease: optimizing patient management. Invited faculty member of the National Kidney Foundation. Available at www.kidney.org.

Hilas O. Pursuit of post-graduate training programs upon graduation. Poster presented at: 2011 ACCP Annual Meeting; October 2011; Pittsburgh, PA.

Hilas O. Clinical interventions of pharmacy practice residents on an acute care for elders unit. Poster presented at: 2011 ACCP Annual Meeting; October 2011; Pittsburgh, PA.

Hilas O. Clinical pearls meet musical chairs: ten timely, expert roundtable discussions. Social and economic considerations of acute elder care. Speaker at: 2011 ASCP CT Senior Symposium; April 2011; Foxwoods, CT.

Other Notable Achievements:
Lavonne C. Cox, R.Ph., Development Board for the Huffington Center on Aging at Baylor College of Medicine. Served on education committee to identify speakers for local events

Jeffrey C. Delafuente, M.S., FCCP, FASCP, elected as a Distinguished Practitioner and Fellow in the National Academies of Practice

Abimbola Farinde: clinical pharmacist appointed as a committee member of the Commission for Certification in Geriatric Pharmacy

Emily P. Peron, Pharm.D., FASCP, BCPS, passed BCPS in October 2011, effective January 2012, and selected for/attended the National Institute on Aging Summer Institute on Aging Research; July 2011

Kayla Smith, Pharm.D., accepted a PGY2 in Geriatrics at the VA Connecticut Healthcare System under the mentorship of Sean Jeffery, Pharm.D., FASCP, to begin July 2012

CGP certification:
Timothy Reilly, Pharm.D., FASCP, BCPS, CGP Mark Wienke, R.Ph., CGP

The GI/Liver/Nutrition PRN currently has 165 members as of March 2012 and continues to focus on the gastrointestinal, hepatology, and nutrition support disciplines.

The PRN will host a focus session at the upcoming 2012 Annual Meeting in Hollywood, Florida. The focus session, Updates in Gastrointestinal Topics, will address selected topics involving probiotics, hepatitis C, and bariatrics.

In addition, a group of PRN members is working on a position paper, “Pharmacy Services Focused in the Area of Hepatitis C Viral Infections.”

The PRN leadership consists of Joe Ybarra, Pharm.D., BCNSP, President; Rima Mohammad, Pharm.D., BCPS, President-Elect; and Pramodini Kale-Pradhan, Pharm.D., Secretary/Treasurer. Finally, we would like to congratulate these PRN members for their accomplishments.

Promotions:
Erin Nystrom, Pharm.D., BCNSP, promoted to an assistant residency program director, PGY1 Pharmacy Practice Residency Program, Mayo Clinic, Rochester, MN

Pramodini Kale-Pradhan, Pharm.D., promoted to Full Professor, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI

Al Roach, Pharm.D., FACG, changed his position to a medical scientist director, Medical Scientific Affairs Department, Ironwood Pharmaceuticals

Publications:
Nystrom EM. Nutrition support in the critically ill. In: Johnson T, ed. Critical Care Therapeutics. Sudbury, MA: Jones & Bartlett, 2012.

McMahon MM, Nystrom EM, Miles JM. Parenteral nutrition in adults. In: Duggan C, Gura K, Jaksic T, eds. Clinical Management of Intestinal Failure. Boca Raton, FL: CRC Press – Taylor & Francis, 2011.

Smith A, Henriksen B, Cohen A. Pharmacokinetic considerations in Roux-en-Y gastric bypass patients. Am J Health Syst Pharm 2011;68:2241–7.

Mort JR, Shiyanbola OO, Ndehi LN, Xu Y, Stacy JN. Opioid-paracetamol prescription patterns and liver dysfunction: a retrospective cohort study in a population served by a US health benefits organization. Drug Saf 2011;34:1079–88.

Wilhelm SM, Petrovitch EA. Implementation of an inpatient anticoagulation teaching service: expanding the role of pharmacy students and residents in patient education. Am J Health Syst Pharm 2011;68:2086–93.

Wilhelm SM, Kale-Pradhan PB. Estimating creatinine clearance: a meta-analysis. Pharmacotherapy 2011;31:658–64.

Wilhelm SM, Johnson JL, Kale-Pradhan PB. Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori. Ann Pharmacother 2011;45:960–6.

Kim JJ, Culley CM, Mohammad RA. Telaprevir: an oral protease inhibitor for hepatitis C virus infection. Am J Health Syst Pharm 2012;69:19–33.

Other Notable Achievements:
April Smith, Pharm.D., M.A., BCPS, Invited Faculty, First Integrated Health Session Pharmacology Course at the 29th Annual Meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS); June 17–22, 2012; San Diego, CA.

The Hematology/Oncology PRN facilitates timely dissemination of information related to the clinical practice, research, and teaching of hematology and oncology among its members and serves as a resource for hematology and oncology expertise to others. The PRN provides a forum for hematology/oncology pharmacists to network and collaborate on scientific, educational, and political issues affecting clinical practice, teaching, and research.

Promotions:
Robert Ignoffo, Pharm.D., founding member of HOPA, has been promoted to an assistant dean of student services at Touro University California.

Awards:
Jai Patel, Pharm.D., a Pharmacogenomic and Oncology Fellow at the UNC Eshelman School of Pharmacy, received the Rho Chi Clinical Research Award.

Grants:
Amanda Clary, Pharm.D., a clinical oncology pharmacist, received a HOPA annual conference grant.

Rebecca Fahrenbruch, Pharm.D., BCOP, an oncology pharmacy manager at Fairview Oncology Pharmacy, received a HOPA annual conference grant.

Other Notable Achievements:
Betsy Poon, Pharm.D., FCCP, Florida Hospital for Children, was elected as the chair of the Children’s Oncology Group pharmacy committee for 2011–2015.

Emily K. Pauli was elected as the 2012 vice chair of the Alabama Comprehensive Cancer Control Coalition.

The Immunology/Transplantation Practice and Research Network (PRN) has grown to more than 350 members! We encourage all members to get involved and to be sure to provide us with suggestions and comments to make our PRN even better.

In February 2012, a request was submitted by ACCP and the American Society of Health-System Pharmacists to the Board of Pharmacy Specialties (BPS) for its consideration of solid organ transplantation pharmacy practice as a new specialty. In a survey distributed to IMTR PRN members in October 2011, 76% of the 166 respondents thought the practice of solid organ transplantation pharmacy should be recognized as a new specialty.

In accordance with its established processes, BPS is expected to review the requests and then consider which areas of potential specialization it will explore through its usual process for consideration of proposed specialties (www.bpsweb.org). To view the request form and learn more about ACCP’s ongoing efforts to expand specialty recognition, please visit www.accp.com/careers/specRecog.aspx.

Through collaborative efforts between our PRN and the AST Transplant Pharmacists Community of Practice (CoP), a white paper providing an overview of clinical pharmacists and pharmacist researchers practicing in the field of transplantation was published in August 2011 on behalf of the American Society of Transplantation Transplant Pharmacy Community of Practice and the American College of Clinical Pharmacy Immunology/Transplantation Practice and Research Network: Alloway RR, Dupuis R, Gabardi S, Kaiser TE, Taber DJ, Tichy EM, Weimert-Pilch NA; Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team. Am J Transplant 2011;11:1576–83.

We look forward to future collaborative publications focusing on transplant pharmacists.

Promotions:
Angela Maldonado: Promotion to a clinical associate professor of pharmacotherapy

Awards:
Nicole Schmidt: American Transplant Congress Young Investigator Award 2012

Grants:
Ian Doyle: Legacy Transplant Services Research Award, Principal Investigator, April 2012 to April 2013

Angela Maldonado: Washington State University Pharmacotherapy Clinical Track Faculty Seed Grant Program Prospective “Donor-Specific Antibody (DSA) Monitoring Protocol to Detect Patient Characteristics and/or Changes in Immunosuppression on the Development of De Novo Antibodies,” August 1, 2011, to August 31, 2012

Kathleen Tornatore: “The Influence of Diabetes on Myfortic (Enteric-Coated Mycophenolic Acid Sodium) Pharmacokinetics and Adverse Drug Effects in Stable African American and Caucasian Renal Transplant Re-cipients” (CERL080AUS91T). Novartis-Investigator Initiative; Principal Investigator, June 2011 to September 2012

“Genomic and Cellular Markers and Chronic Allograft Function” submitted to NIDDK; PAR-06-112: Pilot and Feasibility Clinical Research Grants in Kidney or Urologic Disease (R21) NIDDK, Principal Investigator; funded NIDDK-ARRA September 15, 2009, to September 15, 2011

Publications:
Alloway RR, Vanhaecke J, Yonan N, White M, Haddad H, Rabago G, Tymchak W, Diaz Molina BD, Grimm M, Eiskjaer H, Karpf C, Undre N. Pharmacokinetics in stable heart recipients after conversion from twice-daily to once-daily tacrolimus formulations. J Heart Lung Transplant 2011;30:1003–10.

Barker JH, Alloway RR, Furr A, Banis JC, Cunningham M, Basappa PS, Wiggins O, Frank JM, Woodle ES. Risk assessment and management in hand and facial tissue transplantation. Eur J Trauma Emerg Surg 2011;37:469–76.

Busque S, Cantarovich M, Mulgaonkar S, Gaston R, Gaber AO, Mayo PR, Ling S, Huizinga RB, Meier-Kriesche HU; PROMISE Investigators (Alloway RR). The PROMISE study: a phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de novo kidney transplantation. Am J Transplant 2011;11:2675–84.

Walsh R, Brailey P, Girnita A, Alloway R, Rike-Shields A, Wall G, Basma S, Cardi M, Tevar A, Govil A, Mogilishetty G, Roy-Chaudhury P, Woodle ES. Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition. Transplantation 2011;91:1218–26.

Woodle ES, Alloway RR, Girnita A. Proteasome inhibitor treatment of antibody-mediated allograft rejection. Curr Opin Organ Transplant 2011;16:434–8.

Woodle ES, Walsh RC, Alloway RR, Girnita A, Brailey P. Proteasome inhibitor therapy for antibody-mediated rejection. Pediatr Transplant 2011;15:548–56.

Dick TB, Raines AA, Stinson JB, Collingridge DS, Harmston GE. Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients. Transplant Proc 2011;43:2664–8.

Ensor CR, Trofe-Clark J, Gabardi S, McDevitt-Potter LM, Shullo MA. Generic maintenance immunosuppression in solid organ transplant recipients. Pharmacotherapy 2011;31:1111–29.

Ensor CR, Russell SD, Wittstein IS, Conte JV. Capnocytophaga canimorsus sepsis in an asplenic heart transplant candidate with a left ventricular assist device. Prog Transplant 2011;21:121–3.

Gabardi S, Catell J, Martin ST, Perrone R, Chandraker A, McGee CC, McDevitt-Potter LM. Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients. Ann Pharmacother 2011;45:48–53.

Gabardi S, Halloran P, Friedewald J. Managing risk in developing new transplant immunosuppressive agents: overview of the regulatory environment and risk management opportunities. Am J Transplant 2011;11:1803–9.

Gabardi S, Halloran P, Friedewald J. An update on risk evaluation and mitigation strategies in transplantation [letter to the editor]. Am J Transplant 2012;12:257–8.

Oetting W, Schladt D, Leduc R, Jacobson PA, Guan W, Matas A, Israni A. Lack of validation of SNPs previously associated with acute rejection in kidney transplant recipients by a large multi-center cohort. Transpl Int 2011;24:1231–8.

Passey C, Birnbaum AK, Brundage RC, Oetting WS, Jacobson PA. Dosing equation for tacrolimus using genetic and clinical factors. Br J Clin Pharmacol 2011;72:948–57.

Hardinger KL, Kalluri HV, Bushey S. The current state of renal transplant immunosuppression: present and future. World J Transplant. In press.

Hardinger KL, Hutcherson T, Preston D, Murillo D. The influence of pill burden and medication cost on renal function after transplant. Pharmacotherapy. In press.

Huiras P, Gabardi S. Everolimus: a review of its pharmacologic properties and use in solid organ transplantation. Rev Health Care 2011;2:229–41.

Maldonado AQ, Seiger TC, Urann CL, McCleary JA, Goroski AL, Ojogho ON. Billing for outpatient transplant pharmacy services. Am J Health Syst Pharm 2012;69:144–7.

Martin ST, Torabi MJ, Gabardi S. Influenza in solid organ transplant recipients. Ann Pharmacother 2012;46:255–64.

Martin ST. Therapeutic drug monitoring: a crash course in pharmacokinetics [editorial]. International Society of Heart and Lung Transplantation Links Newsletter 2012;3:257.

McDevitt LM, Sadaka B, Tichy E, Rogers C, Gabardi S. A multicenter experience with generic tacrolimus conversion. Transplantation 2011;92:653–7.

Latran M. Response to Klintmalm on the use of generic immunosuppression. Am J Transplant 2012;12:791.

Sadaka B, Alloway RR, Woodle ES. Clinical and investigational use of proteasome inhibitors for transplant rejection. Expert Opin Investig Drugs 2011;20:1535–42.

Trofe-Clark J, Gabardi S, McDevitt-Potter LM, Alloway RR. Immunosuppression, generic drugs and the FDA [editorial]. Am J Transplant 2012;12:792–3.

Tornatore K, Sudchada P, DiFrancesco R, Wilding G, Dole K, Leca N, Gundroo A, Venuto RC. Mycophenolic acid pharmacokinetics during maintenance immunosuppression in African American and Caucasian renal transplant recipients. J Clin Pharmacol 2011;51:1213–22.

Nainani N, Patel N, Tahir N, Kumar R, Weber-Shrikant E, Gundroo A, Murray B, Tornatore K, Blessios G, Venuto R. Effect of steroid-free low concentration calcineurin maintenance immunosuppression regimen on renal allograft histopathology and function. Nephrol Dial Transplant 2011 Nov 5. [Epub ahead of print]

Tornatore KM, Sudchada P, DiFrancesco RA, Attwood K, Gundroo A, Gray V, Wilding G, Hochreitter J, Venuto RC. Race and drug formulation influence on mycophenolic acid and metabolite pharmacokinetics in stable renal transplant recipients. J Clin Pharmacol. In press.

Book Chapters:
Ensor CR, Doligalski CT. Antibody-mediated rejection of the cardiac allograft. In: Moffatt-Bruce S, ed. Cardiac Transplantation. Rijeka, Croatia: InTech, 2012:23–40.

Hardinger KL, Brennan DB. Presentation, diagnosis and treatment of acute rejection. In: Kobayashi T, Arai R, eds. Acute Rejection: Risk Factors, Management and Complications. Hauppauge, NY: Nova Publishers, 2012. In press.

Hardinger KL, Alford K, Murillo D. The influence of bortezomib on donor-specific antibody reduction in patients with antibody-mediated rejection. In: Cecka JM, Terasaki PI, eds. Clinical Transplants 2010. Los Angeles: Terasaki Foundation Laboratory, 2011.

Pote LA, Lombardi TL. Transplant pharmacy practice. In: Allen LV Jr, ed. Remington: The Science and Practice of Pharmacy, 22nd ed. London: Pharmaceutical Press, 2012. In press.

Gabardi S, Tichy EM. Overview of immunosuppressive therapies in renal transplantation. In: Singh AK, Sayegh MH, Chandraker A, eds. Core Concepts in Renal Transplantation. New York: Springer, 2012:chap 6.

New ACCP Fellows:
Steve Gabardi, Pharm.D., BCPS, Brigham Women’s Hospital, Boston, MA
Christin Rogers, Pharm.D., BCPS, Beth Israel Deaconess Medical Center, Boston, MA
Lisa McDevitt-Potter, Pharm.D., BCPS, Tufts Medical Center, Boston, MA

Other Notable Achievements:
Basma Sadaka: BCPS certification

Other:
New Members
We would like to welcome the following students, residents, and members to the PRN.

Laura Bascom, member
Amanda Bitterman, student
Darina Brezhnev, member
Albert Cifelli, student
Carolyn Cumming, resident
Kathleen Eipers, member
Alexandria Fagan, member
Jennifer Fitch, affiliate member
Andrew Freeman, resident
Matthew Gillespie, resident
Eric Gnesa, student
Jon Godden, member
Amanda Ingemi, resident
Melissa Johnson, member
John Kastanis, student
Sarah Moehlmann, student
Caitlin Musgrave, resident
Ifeanyi Onor, resident
Michael Ott, member
Saumil Parikh, student
Shree Patel, resident
Regina Ramirez, member
Flavia Rasetto, associate member
Kathleen Schilli, member
Jamel Scott, student
Sarah Shao, member
Kristin Smith, member
Liza Takiya, member

Transplant/Immunology Residency and Fellowship
More than 20 programs recruited for transplant residents and fellows for 2012–2013. The PRN would like to congratulate the following programs and individuals who matched, based on information provided by PRN members. We apologize in advance if we inadvertently missed anyone. Congratulations!

Name	Institution	Position
Jennifer Byrns	Duke University Hospital	PGY2
Matt Gillespie	University of Utah Health Care	PGY2
Amanda Ingemi	University of Pittsburgh Medical Center	PGY2
Arin Jantz	The Methodist Hospital(Houston, Texas)	PGY2
Miae Kim	Brigham and Women’s Hospital	PGY2
Hanna Lee	New York-Presbyterian Hospital	PGY2
Marissa Mako	University of Wisconsin Hospital and Clinics	PGY2
Mark Mariski	UC San Diego Health System	PGY2
Mozhgon (Nancy) Moaddab	St Luke’s Episcopal Hospital (Houston, Texas)	PGY2
Ginger Morris	Yale New Haven-Transplantation Center	PGY2
Misbah Moten	Tampa General Hospital	PGY2
Caitlin Musgrave	Medical University of South Carolina	PGY2
Joelle Nelson	University Health System-San-Antonio	PGY2
Bennet Noel	University of Maryland	PGY2
Shree Patel	University of Illinois at Chicago	PGY2
Debra Ramirez	University Health System-San-Antonio	PGY2
Alexa Ray Vanderbilt	University Medical Center	PGY2
Bharath Ravichandran	UC San Diego Health System	PGY2
TrisAnn Rendulic	University of Michigan Hospital and Health System	PGY2
Heather Snyder	Methodist University Hospital (Memphis, Tennessee)	PGY2
Tracy Sparkes	Hospital of the University of Pennsylvania	PGY2
Michael Spinner	Barnes-Jewish Hospital	PGY2
Lacy Ternes	Hennepin County Medical Center	PGY2
Stephen Thai	Ochsner Medical Center	PGY2
Jill Krisl	University of Cincinnati Fellow 2012-2013	(PGY3)
Basma Sadaka	University of Cincinnati Fellow 2011-2013	(PGY4)

2012 ATC Abstracts Accepted
Congratulations to the following PRN members who have had abstracts accepted to the 2012 American Transplant Congress (ATC), to be held in Boston, Massachusetts, June 2–6, 2012.

Rita Alloway
Lyndsey Bowman
Elise Carlson
Rosemary Cross
Kelly DePeiro
Travis Dick
Ian Doyle
Chris Ensor
Ashley Feist
James Fleming
Steve Gabardi
Karen Hardinger
Matt Harris
Amanda Hulbert
Mike Hurtik
Pamela Jacobson
Jennifer Jebrok
Nicole Kenyon
Janice Kerr
John Knorr
Mike Latran
Angela Maldonado
Pamela Maxwell
Lisa McDevitt-Potter
Erin Newkirk
Jeong M. Park
Nicole Pilch
Lindsey Pote
Alexandra Powderly
Basma Sadaka
Nicole Schmidt
Adele Shields
Nimisha Soni
Dave Taber
Eric Tichy
Kathleen Tornatore
Jennifer Trofe-Clark
Crystal Truax
Christie Truscott
Kimi Ueda
Anne Wiland

Congratulations to PRN members Erin Ticehurst and Spencer Martin, who had abstracts accepted to the 2012 International Society for Heart and Lung Transplantation annual meeting in Prague, Czech Republic, and to Kathleen Tornatore, who had an abstract accepted to the 2012 annual meeting of American Society of Clinical Pharmacology & Therapeutics in Washington, DC.

Promotions:
Ryan Bickel was appointed the president of the Michigan Society of Health-System Pharmacists.

Michaelia Dunn was appointed as the Antimicrobial Stewardship Program chair at Indiana University-Arnett Hospital.

Chris Frei was promoted to an associate professor with tenure at the University of Texas at Austin College of Pharmacy (as of September 2012).

Betsy Hirsch received an appointment at the Northeastern University School of Pharmacy as an assistant professor.

Angela Kashuba was promoted to a full professor (November 2011) at the Eshelman School of Pharmacy, UNC Chapel Hill, and was promoted to a vice chair for Research and Graduate Education (November 2011).

Awards:
Chris Frei received a Pharmacy Mentor Award, Texas Society of Health-System Pharmacists (April 2011); a Distinguished Young Alumnus Award, College of Pharmacy, UT Austin (September 2011); and the Society of Infectious Diseases Pharmacists Young Investigator Award (September 2011).

Jessica Holt received the ASHP Best Practice Award, Pharmacist-Led Antibiotic Stewardship Program Reduces Inappropriate Antibiotic Use and Hospital-Acquired Clostridium difficile, and the Minnesota Society of Health-System Pharmacists Rising Star New Practitioner Award.

Dorothy McCoy received the Pharmacy Residency Excellence New Preceptor Award from the American Society of Health-System Pharmacists Research and Education Foundation (2011).

Grants (limited to 3):
Kelly Caudle and L. Lu received a $10,000 grant from the American Association of Colleges of Pharmacy: “Transcriptional Regulation of Fluconazole Susceptibility in Candida parapsilosis” (February 2012).

Kelly Caudle (Principal Investigator) received a $6500 grant from the University Research Council for “The Role of a Hsp40 Co-chaperone in the Negative Regulation of Azole Antifungal Resistance.”

Jessica Cottreau (Principal Investigator) received a $341,791 grant from the CDC for “Improving Hospital-Based Antimicrobial Prescribing Towards Reducing Antimicrobial-Resistant Hospital-Associated Infections.”

Tom Dilworth and Renee-Claude Mercier received the ASHP Foundation Pharmacy Resident Practice-Based Research Grant for 2011–2012 to fund the study titled “Impact of a Pharmacy Adherence Clinic on HIV Medication-Taking Self-efficacy: A Single Group, Pretest-Posttest Study” at the University of New Mexico Health Sciences Center’s HIV clinic.

Jason Gallagher (Principal Investigator) received a $37,834 grant from Merck to perform “A Case-Control Study of Patients with Carbapenem-Resistant and Third-Generation Cephalosporin-Resistant Klebsiella pneumoniae Bacteremia.”

Betsy Hirsch (Coprincipal Investigator) received a $35,000 grant from the St. Luke’s Episcopal Hospital Roderick D. MacDonald Research Fund for “Development of a Rapid and Reliable Screening Method for Detection of Klebsiella pneumoniae Carbapenemase (KPC)-Producing Isolates in SLEH.”

Angela Kashuba (Principal Investigator) received the following grants: “ULPC-MS/MS to Support Preclinical and Clinical Pharmacology Studies in HIV Treatment and Prevention” from the Institutional Development Grant Program, North Carolina Biotechnology Center, $200,000.00. “Preventing HIV Infection in Women: Targeting Antiretrovirals to Mucosal Tissues,” U01 AI095031 (NIAID) 8/2011–7/2014, $2700.00. “UPLC-MS/MS to Support Preclinical and Clinical Antiretroviral Pharmacology Studies.” S10 RR026581 (NCRR), 8/2011, $402,500.

Publications (limited to 3):
Benefield RJ, Hinde GK, Abolnik IZ. Osteomyelitis due to linezolid-resistant Staphylococcus epidermidis. Clin Infect Dis 2012 Feb 14. [Epub ahead of print]

Bland CM, Bookstaver PB, Thomas S. Successful rechallenge of daptomycin therapy after initial rhabdomyolysis with co-administration of simvastatin. Int J Antimicrob Agents 2011;38:549–50.

Caudle KE, Inger AG, Butler DR, Rogers PD. Echinocandin use in the neonatal intensive care unit. Ann Pharmacother 2012;46:108–16.

Tillman EM, Caudle KE. Training pathways for clinical pharmacy investigators: Pharm.D.-only or Pharm.D./Ph.D.: the trainee’s perspective. Pharmacotherapy 2011;31:58e–62e.

Caudle KE, Wiederhold NP, Barker KS, Rogers PD. Genome-wide expression profile analysis of the Candida glabrata Pdr1p regulon. Eukaryot Cell 2011;10:373–83.

Forcade NA, Wiederhold NP, Ryan L, Talbert RL, Frei CR. Antibacterials as adjuncts to incision and drainage for adults with purulent methicillin-resistant Staphylococcus aureus (MRSA) skin infections. Drugs 2012;72:339–51.

Frei CR, Daniels KR. Potential complications of Medicare reimbursement policy regarding health-care-associated infections. Am J Health Syst Pharm 2012;69:190.

Akers KS, Cota JM, Frei CR, Chung KK, Mende K, Murray CK. Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration. Antimicrob Agents Chemother 2011;55:4639–42.

Attridge RT, Frei CR. Health care-associated pneumonia: an evidence-based review. Am J Med 2011;124:689–97.

Frei CR, Bell AM, Traugott KA, et al. A clinical pathway for community-acquired pneumonia: an observational cohort study. BMC Infect Dis 2011;11:188.

Frei CR, Labreche MJ, Attridge RT. Fluoroquinolones in community-acquired pneumonia: guide to selection and appropriate use. Drugs 2011;71:757–70.

Oramasionwu CU, Brown CM, Lawson KA, Ryan L, Skinner J, Frei CR. Differences in national antiretroviral prescribing patterns between black and white patients with HIV/AIDS, 1996-2006. South Med J 2011;104:794–800.

Oramasionwu CU, Daniels KR, Labreche MJ, Frei CR. The environmental and social influences of HIV/AIDS in sub-Saharan Africa: a focus on rural communities. Int J Environ Res Public Health 2011;8:2967–79.

Gallagher JC, MacDougall C. Antibiotics Simplified, 2nd ed. Sudbury, MA: Jones & Bartlett Learning, 2012.

Heil E, Daniels L, Walko C, Nicolau D, Smith E. Validation of doripenem dosing in patients with end-stage renal disease receiving hemodialysis. Ann Pharmacother 2011;45:1455–6.

Heil E, Corbett A. Guidelines for the use of extended-release nevirapine in HIV-infected patients. Expert Opin Pharmacother 2011;12:2713–8.

Hirsch EB, Cottreau JM, Caeiro JP, Johnson ML, Tam VH. Prospective validation of a model to predict mortality following Pseudomonas aeruginosa bacteremia. Diagn Microbiol Infect Dis 2012;72:97–102.

Hirsch EB, Cottreau JM, Ikwuagwu JO, Lusardi KT, Mohr JF, Rodriguez SM, Shah DN, Tran TT; on behalf of the Houston Infectious Diseases Network. Significant publications in infectious diseases pharmacotherapy in 2010. Am J Health Syst Pharm 2011;68:2075–85.

Hirsch EB, Chang KT, Lasco TM, Caeiro JP, Tam VH. Emergence of KPC-producing Klebsiella pneumoniae (KPC-Kp) in Texas. Diagn Microbiol Infect Dis 2011;69:234–5.

Johnson MD, Plantinga TS, van de Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Laird G, Oosting M, van der Meer J, van Dissel JT, Walsh TJ, Perfect JR, Kullberg BJ, Scott WK, Netea MG. Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study. Clin Infect Dis 2012;54:502–10.

Rosentul DC, Plantinga TS, Scott WK, Alexander BD, van de Geer NMD, Perfect JR, Kullberg BJ, Johnson MD, Netea MG. The impact of caspase-12 on susceptibility to candidemia. Eur J Clin Microbiol Infect Dis 2012;31:277–80.

Plantinga TS, Johnson MD, Scott WK, van de Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Kremer D, Laird GM, Oosting M, Joosten LAB, van der Meer JM, van Dissel JT, Walsh TJ, Perfect JR, Kullberg BJ, Netea MG. Toll-like receptor-1 polymorphisms increase susceptibility to candidemia. J Infect Dis 2012;205:934–43.

Dodds Ashley ES, Johnson MD. Combination antifungal therapy. In: Kauffman C, Pappas PG, Sobel JD, Dismukes WE, eds. Essentials of Clinical Mycology, 2nd ed. New York: Springer, 2011:Part II:153–63.

Adams J, Kashuba ADM. Formulation, pharmacokinetics and pharmacodynamics of topical microbicides. Best Pract Res Clin Obstet Gynaecol 2012 Feb 3. [Epub ahead of print]

Kashuba ADM, Patterson KB, Dumond JB, Cohen MS. Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet 2011 Dec 6. [Epub ahead of print]

Patterson KB, Prince HA, Kraft E, Jenkins AJ, Shaheen NJ, Rooney JF, Cohen MS, Kashuba ADM. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med 2011;3:112re4.

Veronese F, Anton P, Fletcher CV, DeGruttola V, McGowan I, Becker S, Zwerski S, Burns D; Workshop Organizing Committee. Implications of HIV PrEP trials results. AIDS Res Hum Retroviruses 2011;27:81–90.

King EA, McCoy D, Desai S, Nyirenda T, Bicking K. Vancomycin-resistant enterococcal bacteraemia and daptomycin—are higher doses necessary? J Antimicrob Chemother 2011;66:2112–8.

McCoy D, Toussaint K, Gallagher JC. The pharmacist’s role in preventing antibiotic resistance. U S Pharmacist 2011;36:42–9. Also cited on Medscape Pharmacists – MedPulse Newsletter Top Stories 8/16/2011.

McCoy D, Wong E, Kuyumjian AG, Wynd MA, Sebti R, Munk GB. Treatment of respiratory syncytial virus infection in adult patients with hematologic malignancies based on an institution-specific guideline. Transpl Infect Dis 2011;13:117–21.

Thomas Z, McCoy D. Anti-infectives. In: Kane-Gill SL, Dasta J, eds. High Risk IV Medications in Special Patient Populations. London: Springer-Verlag, 2011:153–204.

Messina AF, Namtu K, Guild M, Dumois JA, Berman DM. Trimethoprim-sulfamethoxazole therapy for children with acute osteomyelitis. Pediatr Infect Dis J 2011;30:1019–21.

Snyder AM, Klinker K, Orrick J, et al. In-depth analysis of medication errors in hospitalized patients with HIV. Ann Pharmacother 2011;45:459–68.

Stover KR, Riche DM, Gandy CL, Henderson H. What would we do without metronidazole? Am J Med Sci 2011 Aug 3. [Epub ahead of print]

Stover KR, Molitorisz S, Swiatlo E, Muzny CA. A fatal case of Kaposi sarcoma due to immune reconstitution inflammatory syndrome. Am J Med Sci 2012 Jan 6. [Epub ahead of print]

Phillippe HM, Darling CH, Aikens GB, Wargo KA. Development of an antibiogram in a long-term care facility. Consult Pharm 2011;26:829–36.

New ACCP Fellows:
Patricia Aubert from Sanford Children’s Hospital and Sanford Medical Hospital in Sioux Falls, South Dakota

Other Notable Achievements:
Kurt Wargo received Added Qualifications in ID (AQ-ID).

Eight members became Board Certified Pharmacotherapy Specialists (BCPSs): Patricia Aubert, John Boreyko, Brian Dial, Michaelia Dunn, Ryan Kuhn, Amy Landers, Yanina Pasikhova, and Sally A. Tice.

One of the major accomplishments for the PRN in 2011 was the publication of “Comparative Evaluation of the Cockcroft-Gault Equation and the Modification of Diet in Renal Disease (MDRD) Study Equation for Drug Dosing: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy” in the November 2011 issue of Pharmacotherapy.

In addition, the PRN offered its first travel award for a trainee to attend the 2011 ACCP Annual Meeting in Pittsburgh, Pennsylvania. The recipient of the travel award was Shailly Shah, a pharmacy student at the University of Pittsburgh. She presented the results of a project she completed with Tom Nolin, Pharm.D., Ph.D., and Karen Nenno, titled “Knowledge, Perceptions, and Adherence of ESRD Patients Receiving Erythropoietic Therapy and Anemia Management: A Student Pharmacist Based Survey in an Outpatient Peritoneal Dialysis Clinic.” The paper was presented at the Nephrology PRN business and networking forum held on October 18, 2011, during the ACCP Annual Meeting.

The Nephrology PRN is looking forward to offering a travel award to a student, resident, or fellow attending the 2012 Annual Meeting. Work is also under way within the PRN to develop a mentoring program to connect members who are looking for mentorship in clinical or research arenas with more experienced members.

Publications:
Eyler RF, Mueller BA. Antibiotic dosing in critically ill patients with acute kidney injury. NatRevNephrol 2011;7:226–35.

Ghannoum M, Nolin TD, Lavergne V, Hoffman RS, Bunchman TE, Burdmann EA, Calello DP, Dalhoff KP, Dargan PI, Goldfarb DS, Jurrlink DN, Kielstein JT, Laliberté M, Lavonas EJ, Li Y, Liu KD, Maclaren R, Mégarbane B, Mowry JB, Mueller BA, Roberts DM, Winchester JF. Blood purification in toxicology: nephrology’s ugly duckling. Adv Chronic Kidney Dis 2011;18:160–6.

Mueller BA, Crompton JA, Donovan BJ, Yankalev S, Lamp KC. Safety of daptomycin in patients receiving hemodialysis. Pharmacotherapy 2011;31:665–72.

Mueller BA, Scoville BA. Adding to the armamentarium: antibiotic dosing in extended dialysis. Clin J Am Soc Nephrol 2012;7:373–5.

Pasko DA, Churchwell MD, Salama NN, Mueller BA. Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy. Blood Purif 2011;32:82–8.

Pierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Perit Dial Int 2012 Feb 1. [Epub ahead of print]

Vilay AM, Grio M, DePestel DD, Sowinski KM, Gao L, Heung M, Salama NN, Mueller BA. Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis. Crit Care Med 2011;39:19–25.

New ACCP Fellows:
Joanna Hudson, Pharm.D.; Memphis, TN
Thomas Nolin, Pharm.D., Ph.D.; Pittsburgh, PA

Other Notable Achievements:
Joanna Hudson: Named Fellow of the National Kidney Foundation
Bruce Mueller: Named Fellow of the National Kidney Foundation
Wendy St. Peter: Named Fellow of the National Kidney Foundation
Amy Barton Pai: Appointed to a 3-year term on the Dialysis Advisory Group

Other:
Michael Schwenk presented “Tackling Risks for Cardiovascular Disease, the Pharmacist’s Perspective” at the National Kidney Foundation, Serving
Greater New York, Fifth Annual Regional Symposium on Chronic Kidney Disease; March 2012; New York City, NY.

Update on Board Certification in Pain and Palliative Care:
The Board of Pharmacy Specialties has collected and analyzed the recent survey to determine whether the knowledge, tasks, and skills identified by the practice analysis task force are actually what a pain and palliative care pharmacist does on a day-to-day basis. We are now waiting on a call for the petition. PRN members can do their part by speaking to ACCP leadership to support the pain and palliative care petition.

Welcome New Members:
Bernard Cino
Amanda Clary
Ryan Costantino
Matthew Foster
Kyle Hacker
Kelly Hoenig
Lee Hwei Khien
Farzana Musawwir
Edith Nutescu
Michael Smith
Lee Stringer

Accomplishments:
Nancy Alvarez: Trustee-at-Large candidate for the American Pharmacists Association

Jeffrey Fudin: Director of PGY2 Pharmacy Pain Residency at Stratton VA Medial Center

Rob Hutchison: Board Certification in Ambulatory Care Pharmacy

Mary Lynn McPherson:
Developed the ASHP Foundation Pain Management Level 1 and 2 Training: Led the effort to develop this online learning experience for pharmacists internationally. Level 1 is 6 modules on basic pain management; level 2 is 10 modules that apply the knowledge taught in level 1. Hundreds of pharmacists around the world have completed this training.
University of Maryland, Baltimore, Trailblazer Award. Women’s History Month Celebration, University of Maryland School of Pharmacy Fellow, American Society of Consultant Pharmacists (ASCP)
Fellow (inaugural), American Society of Pain Educators (FASPE)
University of Maryland School of Pharmacy Alumni Association Evander Frank Kelly Honored Alumnus Award Fellow, American Society of Pain Educators (FASPE); inaugural selection

Publications:
Jeffrey Fudin
Brennan MJ, Fudin J, Perkins RJ. Opioid Calculator Online. Practical Pain Management (incorporating the “Methadone Fudin Factor”). January 2012. Available at http://opioidcalculator.practicalpainmanagement.com/.

Crana S, Fudin J. Drug interactions among HIV patients receiving concurrent antiretroviral and pain therapy. Pract Pain Manag 2011;11:105–18,120–4.

Fudin J. Update on Risk Evaluation and Mitigation Strategies (REMS) associated with long-acting opioids. CE program of the University of Connecticut School of Pharmacy and Drug Topics. Drug Top 2011 October:45–58.

Fudin J. Opioid pain management: balancing risks and benefits. CE program of the University of Connecticut School of Pharmacy and Drug Topics. Drug Top 2011 September:46–58.

Zorn KE, Fudin J. Treatment of neuropathic pain: the role of unique opioid agents. Pract Pain Manag 2011;11:26–33.

Mary Lynn McPherson
Kim M, McPherson ML. Pharmacodynamics in the elderly. In: Core Curriculum for the Palliative Long-term Care Nurse. Pittsburgh: Hospice and Palliative Care Nurses Association, 2012.

McPherson ML, Telegadis T. Nonopioid pharmacotherapy of pain in older adults. In: Handbook of Pain Relief in Older Adults: An Evidence-Based Approach, 2nd ed. Totowa, NJ: Humana Press, 2011.

McPherson ML, Telegadis T. Opioid pharmacotherapy of pain in older adults. In: Handbook of Pain Relief in Older Adults: An Evidence-Based Approach, 2nd ed. Totowa, NJ: Humana Press, 2011.

McPherson ML. Frequent pharmacological interactions in palliative care. In: Yennurajalingam S, Bruera E, eds. Oxford American Handbook of Hospice and Palliative Medicine. Oxford University Press.

Uritsky TJ, McPherson ML, Pradel F. Assessment of hospice health professionals’ knowledge, views, and experience with medical marijuana. J Palliat Med 2011;14:1291–5.

Interviewed for article, What are the best safety practices for use in methadone in the treatment of pain? Conversations with Lynn R. Webster, M.D., and Mary Lynn McPherson, Pharm.D., BCPS, CPE. Pract Pain Manag 2012;12:76–8.

McPherson ML. Pain medications increase death rate. Get Better Health Blog (getbetterhealth.com); November 2011. Picked up by The New York Times.

Invited Presentations:
Jeffrey Fudin
December 9, 2011 – Palliative care: an interdisciplinary symposium. Presented at: The Institute for Continuing Education, The Times Center; New York, NY.

October 17, 2011 – Opioid REMS: helpful or painful? Presented as part of the Pharmaceutical Industry, Hematology/Oncology, and Pain and Palliative Care PRNs’ focus session. The role of clinical pharmacists in Risk Evaluation and Mitigation Strategies (REMS) programs. American College of Clinical Pharmacy Annual Meeting, David L. Lawrence Convention Center; Pittsburgh, PA.

October 5, 2011 – New Jersey Dental Surgeons Association. A Continuing Education Lecture Series on Pain Management (4.5 hours) to include pre-emptive analgesia, opioid therapy, risk management, neuropathic pain, and REMS. Presented at: Woodbridge Hilton Hotel; Woodbridge, NJ.

September 27, 2011 – PharmEd presentation (American Health Resources). Current trends in opioid use to manage pain and minimize abuse. Presented at: Doubletree Guest Suites; Mt. Laurel, NJ.

September 18, 2011 – Current trends in opioid use to manage pain and minimize abuse. Presented at: Pain Management Symposium at the Albany College of Pharmacy and Health Sciences; Albany, NY.

July 30, 2011 – PharmEd presentation (American Health Resources). Two sessions: Improving patient care and The role of opioid REMS and current trends in opioid use to manage pain and minimize abuse. Marriott Charleston; Charleston, SC.

June 30, 2011 – Update on opioid therapy: recent trends of use and abuse. Presented at: Pharmaceutical Society of the State of New York (PSSNY) annual convention. Ft. William Henry Hotel; Lake George, NY.

June 7, 2011 – PharmEd presentation (American Health Resources). Current trends in opioid use to manage pain and minimize abuse. Hilton Boston/Woburn Hotel; Woburn, MA.

June 1, 2011 – PharmEd presentation (American Health Resources). Current trends in opioid use to manage pain and minimize abuse. Marriott Buffalo Niagara; Buffalo, NY.

Chris Herndon
McPherson ML, Herndon CM, Kral L. Pathophysiology, pharmacology, and therapeutics: connecting the dots in advanced pain management. Presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

McPherson ML. In: Strickland J, McPherson ML, Herndon C, Dole E. Long-acting opioids: best practice or all hype? Squabbling about pain: current controversies in chronic pain management with opioids. Presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

Lee Kral
McPherson ML, Herndon CM, Kral L. Pathophysiology, pharmacology, and therapeutics: connecting the dots in advanced pain management. Presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

Mary Lynn McPherson
Kim M, McPherson ML, Kopochis E, Weiss S. Impact of an electronic medication reporting program in a hospice organization. Poster presented at: The Annual Assembly of the American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association; March 2012; Denver, CO.

Kim M, McPherson ML. Medication error reporting in hospice. Poster presented at: The Annual Assembly of the American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association; March 2012; Denver, CO.

McPherson ML, Watson K, Kendall M, Haines S. Teaching certificate program at the University of Maryland School of Pharmacy. Poster presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

Kim M, McPherson ML. Medication error reporting in hospice. Poster presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

Kim M, McPherson ML, Kopochis E, Weiss S. Impact of an electronic medication reporting program in a hospice organization. Poster presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

McPherson ML, LaPenta M. It’s not your mama’s end-of-life medication bag! Preconference at: Annual Assembly of the American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association; March 2012; Denver, CO.

McPherson ML, Davis M, Bruera E, Del Fabbro E. A critical review of evidence-based non-pain symptom management at end of life. Preconference at: Annual Assembly of the American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association; March 2012; Denver, CO.

Walker K, McPherson ML. Speed dating with pharmacists: 50 practical medication tips at end of life. Presented at: Annual Assembly of the American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association; March 2012; Denver, CO.

McPherson ML, Walker K. Stick it to me: topical and transdermal analgesics at end of life. Presented at: Annual Assembly of the American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association; March 2012; Denver, CO.

McPherson ML. New drugs and drug news of 2011. Presented at: Maryland Pharmacists Association and Maryland ASCP; February 2012; Baltimore, MD.

McPherson ML. Drug selection: differentiating pain medications and utilizing a multimodal treatment approach. In: Holmquist GL, de Leon-Casasola O, McPherson ML, Herndon CM. Patient-Centered Approach to Pain Management: Improving Outcomes One Case at a Time. Presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

McPherson ML. New drugs in pain and palliative care: ambulatory care focus. In: Bickel RJ, McPherson ML, Wheeler RE. Focus on New Drugs in Pain and Palliative Care. Presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA. McPherson ML. Pain and palliative care specialist. In: Career Pearls: Days in the Lives of Health-System Pharmacists. Presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

McPherson ML. Getting the word out: being an effective author in the marketplace. In: Professional and Academic Publishing: Putting Your Ideas into Practice. Presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

McPherson ML, Herndon CM, Kral L. Pathophysiology, pharmacology, and therapeutics: connecting the dots in advanced pain management. Presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

McPherson ML. Long-acting opioids: best practice or all hype? In: Strickland J, McPherson ML, Herndon C, Dole E. Squabbling About Pain: Current Controversies in Chronic Pain Management with Opioids. Presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

McPherson ML. Opioid treatment agreements in chronic pain management: useful practice or one more piece of paper to file? In: Strickland J, McPherson ML, Herndon C, Dole E. Squabbling About Pain: Current Controversies in Chronic Pain Management with Opioids. 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

McPherson ML. Pain and symptom management. A two-day intensive workshop. Presented at: The Carolinas Center for Hospice & End of Life Care; November 2011; Charlotte, NC.

McPherson ML, Wertheimer D, Shub V, Greenberg-Slovin N. Palliative care: a bridge of compassion between curing and caring. Presented at: The Geriatrics and Gerontology Education and Research Program, University of Maryland School of Pharmacy; October 2011; Baltimore, MD.

Pamela S. Moore
Barnstorming, directing, & producing: integration of a clinical pharmacist across the continuum of palliative care and hospice services. Radwany S, Moore PS. American Academy of Hospice and Palliative Medicine; March 7–10, 2012; Denver, CO.

Richard Wheeler
McPherson ML. New drugs in pain and palliative care: acute care focus. In: Bickel RJ, McPherson ML, Wheeler RE. Focus on New Drugs in Pain and Palliative Care. Presented at: 46th ASHP Midyear Clinical Meeting & Exhibition; December 2011; New Orleans, LA.

The Pediatrics PRN is pleased to recognize the following accomplishments of its members.

Promotions:
Sarah Smith was promoted to the vice chair of Clinical and Administrative Services at Sullivan University College of Pharmacy.

Awards:
Brad/ley McCrory received the Patient Education Advocacy Award for the Cincinnati Children’s Hospital Medical Center.

Publications:
LaRochelle JM, King A. Avoiding plagiarism [editorial]. Hosp Pharm J 2011;46:917–9.

LaRochelle JM, Diaz CJ. Evaluation of pediatric pharmacotherapy education in a college of pharmacy. Curr Pharm Teach Learn 2011;3:313–9.

LaRochelle J. Educational interventions to decrease the number of vancomycin levels in a pediatric hospital [letter to the editor]. Hosp Pharm J 2011;46:642–3.

LaRochelle J, King A, Tanas M, Day K, Marshall H, Tyler A. Writing a review article. Am J Health Syst Pharm 2011;68:790–3.

Messina AF, Namtu K, Guild M, Dumois JA, Berman DM. Trimethoprim-sulfamethoxazole therapy for children with acute osteomyelitis. Pediatr Infect Dis 2011;30:1019–21.

Broome L, So TY. An evaluation of initial vancomycin dosing in infants, children, and adolescents. Int J Pediatr 2011;2011:470364.

Broome L, So TY. Neonatal abstinence syndrome: a review on clonidine’s place in therapy. NeoReviews 2011;12:e575–e584.

Kautza S, So TY. Ceftriaxone-induced hemolysis in pediatric patients with sickle cell disease. J Pediatr Sci 2011;3:e83.

Daniels T, So TY. Fidaxomicin for the treatment of Clostridium difficile infection in the pediatric population – not quite so soon yet. Gastroenterol Res 2011;4:93–6.

Wier HA, Cerna A, So TY. Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview. Paediatr Drugs 2011;13:97–106.

So TY, Layton JB, Farrington E, Gipson PE, Gibson K, Primack W, Conley W III, Gipson DS, Ferris M. Cognitive pharmacy services at a pediatric nephrology and hypertension clinic. Ren Fail 2011;33:19–25.

Coulter CJ, Smith S. The impact of preclass reading assignments on class performance. Curr Pharm Teach Learn 2012. In press.

New ACCP Fellows:
Catherine Crill, Collin Hovinga, Donna Krauss, and Jennifer Le were inducted as new ACCP Fellows at the 2011 Annual Meeting.

Other Notable Achievements:
Bill Greene, chief pharmaceutical officer for St. Jude Children’s Research Hospital, provided testimony on drug shortages before the Health Subcommittee of the House Energy and Commerce Committee in February 2012.

Notable Member Achievements

Awards:
Mary Ensom received the 2011 American College of Clinical Pharmacy (ACCP) Education Award “for major contributions to advancing clinical pharmacy education.”

Eric Poulin, Mary Ensom, Erica Greanya, and Nilu Partovi received the 2011 Publication Award, B.C. Branch (Review Article Category) C.S.H.P., for their paper: Poulin E, Greanya E, Partovi N, Shapiro RJ, Al-Khatib M, Ensom MHH. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens. Ther Drug Monit 2011;33:50–5.

Sarah Stabler and Mary Ensom received the 2011 Publication Award, B.C. Branch (Original Research Category) C.S.H.P., for the following paper: Stabler SN, Ensom MHH. Extended-interval aminoglycoside therapy for adult patients with febrile neutropenia: a systematic review. Can J Hosp Pharm 2011;64:182–91.

Grants:
Mary Ensom is one of four 2011 Canadian Society of Hospital Pharmacists (CSHP) grant recipients for a project titled “Stability of Propranolol in Extemporaneously Compounded Suspensions: New Formulations for an Old Drug” ($10,000).

Publications:
Mary Ensom
Barry AR, Ensom MHH. A new analogy for teaching the well-stirred model to pharmacy students. Int J Pharm Educ Pract (IJPEP) 2011;7:1–7.

Ensom MHH. Improving the chances of manuscript acceptance: how to address peer reviewers’ comments. Can J Hosp Pharm 2011;64:389–91.

Zed PJ, Ensom MHH, Slavik RS, Brown G, Wilbur K, Kanji S, Koshman S, Irvine-Meek J,Perreault M, Zelenitsky S. Evaluation of the research grant program of the Foundation of the Canadian Society of Hospital Pharmacists, 1995-2008. Can J Hosp Pharm 2011;6:399–404.

Wang EHZ, Mabasa VH, Loh GW, Ensom MHH. Haloperidol dosing strategies in the treatment of delirium in the critically-ill. Neurocrit Care 2012;16:170–83.

Edwards A, Ensom MHH. Pharmacokinetic effects of bariatric surgery. Ann Pharmacother 2012;46:130–6.

Su VCH, Harrison J, Rogers C, Ensom MHH. Belatacept: a new biologic and its role in kidney transplantation. Ann Pharmacother 2012;46:57–67.

Teng JFT, Mabasa VH, Ensom MHH. The role of therapeutic drug monitoring of imatinib in chronic myeloid leukemia (CML) and metastatic or unresectable gastrointestinal stromal tumor (GIST) patients. Ther Drug Monit 2012;34:85–97.

Greanya E, Poulin E, Partovi N, Shapiro RJ, Al-Khatib M, Ensom MHH. Pharmacokinetics of tacrolimus and mycophenolate and its glucuronidated metabolites in stable renal transplant recipients on a steroid-free regimen. Am J Health Syst Pharm 2012;68:134–42.

Mah G, Mabasa VH, Chow I, Ensom MHH. Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review. Ann Pharmacother 2012;46:265–75.

Phillips JC, Oliffe JL, Ensom MHH, Bottorff JL, Bissell LJL, Boomer J, O’Brien KM, Howard T, Khara M, Bottorff JL. An overlooked majority: HIV-positive gay men who smoke. J Mens Health 2012;9:17–24.

Häfeli UO, Ensom MHH, Kiang TKL, Stoeber B, Chua B, Pudek M, Schmitt V. Comparison of vancomycin concentrations in blood and interstitial fluid: a possible model for less invasive therapeutic drug monitoring. Clin Chem Lab Med 2011;49:2123–5.

The Women’s Health PRN has been busy in recent months. PRN activities have included development and dissemination of our PRN newsletter, development of a PRN mission statement, and introduction of plans for increased student involvement within the PRN. In addition, our members have been very productive in their individual practices.

Promotions:
Gerald Briggs, BPharm, FCCP, was appointed as an adjunct professor, Department of Pharmacotherapy, Washington State University, Spokane.

Sarah Shrader, Pharm.D., BCPS, CDE, was appointed as an associate professor in the College of Pharmacy and an adjunct associate professor in the College of Medicine, Department of Clinical Pharmacy and Outcomes Sciences/Family Medicine, South Carolina College of Pharmacy, MUSC Campus.

Karen Whalen, Pharm.D., BCPS, CDE, was appointed as an associate chair of the Department of Pharmacotherapy & Translational Research, College of Pharmacy, University of Florida.

Grants:
Cheang KI. May 1, 2011, to April 30, 2013. “Racial Differences in Insulin Resistance Before and During Pregnancy in Women with the Polycystic Ovary Syndrome.” Source: NIH and VCU National Center on Minority Health and Health Disparities; amount: $68,750; role: Pilot Project Principal Investigator

Cheang KI. July 1, 2011, to June 30, 2013. “Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in African-American vs. Caucasian Women.” Source: American Heart Association; amount: $153,996; role: Principal Investigator

Briggs GG. “Determine the Pharmacokinetics of Targeted Drugs in Breast Milk.” Role: Coprincipal Investigator

Publications:
Ragland D, Briggs GG, Wasik M, et al. Obstetrical opportunities: will pharmacy ever realize them? Ann Pharmacother 2012;46:297–300.

Briggs GG. Updates: September 2011, December 2011, March 2012 for: Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 9th ed. Philadelphia: Lippincott Williams & Wilkins, 2011.

Karjane NW, Cheang KI, Mandolesi GA, Stovall DW. Persistence with oral contraceptive pills vs. metformin in women with polycystic ovary syndrome. J Womens Health (Larchmt) 2012 Feb 10. [Epub ahead of print]

Vinluan CM, Zreikat HH, Levy JR, Cheang KI. Comparison of different metabolic syndrome definitions in prediction of future cardiovascular events in the elderly. Metabolism 2012;61:302–9.

Essah PA, Arrowood JA, Cheang KI, Adawadkar SS, Stovall DW, Nestler JE. Effect of combined metformin and oral contraceptive on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome. Fertil Steril 2011;96:501–4.

Cheang KI, Essah PA, Sharma S, Wickham EP, Nestler JE. Divergent effect of a combined hormonal oral contraceptive on metabolic factors in lean versus obese women. Fertil Steril 2011;96:353–9.

Cheang KI, Lucidi RS, Baillargeon JP, Essah PA, Nestler JE. Racial difference in insulin resistance between African-American and Caucasian women with polycystic ovary syndrome. In: Annual Meeting of the American Society for Reproductive Medicine; October 17, 2011; Orlando, FL.. Fertil Steril 2011(3 suppl 1):S128–S129. Abstract.

Cheang KI, Arrowood JA, Essah PA, Lucidi RS, Nestler JE. Racial differences in endothelial function between African-American and Caucasian women with PCOS. Poster presented at: 9th Annual Meeting of Androgen Excess & PCOS Society; October 13, 2011; Orlando, FL. Abstract.

Reilly ER, Cheang KI, Downs RW Jr, Bachmann LM, Nestler JE. Effect of lowering serum insulin with diazoxide on vitamin D levels in obese women with and without polycystic ovary syndrome. Presented at: American Clinical and Climatological Association Annual Meeting; 2011; Sarasota, FL. Abstract.

McBane S, Painter NA, Lee KC, Ma JD, Bourne PE, Halpert JR, Taylor PW, Kuo GM. Bridging the gap between science and practice through the PharmGenEd™ program [abstract]. Am J Pharm Educ 2011;75:Article 105.

McBane S, Painter NA, Lee KC, Ma JD, Bourne PE, Halpert JR, Taylor PW, Kuo GM. Bridging the gap between science and practice through the PharmGenEd™ program. Poster presented at: American Association of Colleges of Pharmacy Annual Meeting; July 2011; San Antonio, TX. Abstract.

Bougetz A, Elder N, Estep G, Kandilian R, Kocher K, Le K, Lew M, Ly T, McBane S, Colbert J. How the opening of new schools in California may affect pharmacy manpower. American Pharmacists Association Annual Meeting; March 2012; New Orleans, LA. Abstract.

Elder N, Estep G, Kandilian R, Kocher K, Le K, Lew M, Ly T, McBane S, Colbert J. How the opening of new schools in California may affect pharmacy manpower. Drug Top. February 15, 2012:22–6.

Gleason BL, Peeters MJ, Resman-Targoff BH, Karr S, McBane S, Kelley K, Thomas T, Denetclaw T. An active learning strategies primer for achieving ability-based educational outcomes. Am J Pharm Educ 2011;75:Article 186.

McBane S. Osteoporosis: a review of current recommendations and emerging treatment options [cover article]. Formulary 2011;46:432–46.

McBane S. Drugs in dermatology: spinosad. J Dermatol Physician Assist. Winter 2012;6:32.

Thomas T, Karr S, Kelley K, McBane S. Overcoming barriers to scholarly activity in a clinical practice setting. Am J Health Syst Pharm 2012;69:465–7.

Kee VR, Gilchrist B, Granner MA, Sarrazin NR, Carnahan RM. A systematic review of validated methods for identifying seizures, convulsions, or epilepsy using administrative and claims data. Pharmacoepidemiol Drug Saf 2012;21(suppl 1):183–93.

Carnahan RM, Kee VR. A systematic review of validated methods for identifying transfusion-related ABO incompatibility reactions using administrative and claims data. Pharmacoepidemiol Drug Saf 2012;21(suppl 1):230–5.

McIntosh J, Tsikitas L, Dennis A. Low-income women’s access to contraception after health care reform in Massachusetts: experiences at the pharmacy. J Am Pharm Assoc. In press.

Dennis A, Clark J, Córdova D, McIntosh J, Edlund K, Wahlin B, Tsikitas L, Blanchard K. Access to contraception after health care reform in Massachusetts: a mixed-methods study investigating benefits and barriers. Contraception 2012;85:166–72.

McIntosh J, Rafie S, Wasik M, McBane S, Lodise NM, El-Ibiary SY, Forinash A, Kachlic MD, Rowe E, Besinque K. Oral contraceptives from prescription to over-the-counter status: an opinion statement of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2011;31:424–37.

Tocco AM, Chang F, Kleinow ME, Hwang JM, Garwood CL, Khreizat HS, O’Connell MB. Classifications of drug-related problems discovered during senior brown bag medication reviews. Presented at: American College of Clinical Pharmacy Annual Meeting; 2011; Pittsburgh, PA. Abstract.

Gupta NA, Chang F, Kleinow ME, Hwang JM, Garwood CL, Khreizat HS, O’Connell MB. Patient satisfaction and self-perceived knowledge gained during senior brown bag medication reviews. Presented at: American College of Clinical Pharmacy Annual Meeting; 2011; Pittsburgh, PA. Abstract.

Gupta NA, Chang F, Kleinow ME, Hwang JM, Garwood CL, Khreizat HS, O’Connell MB. Evaluation of patient education on preventive health measures and poison control center awareness during senior brown bag medication reviews. Presented at: American College of Clinical Pharmacy Annual Meeting; 2011; Pittsburgh, PA. Abstract.

Rutkowski KM, Freitel KM, Rosenthal TC, Smith GB, O’Connell MB. Experiential value of an older adult medication assessment early in the pharmacy curriculum. Presented at: American College of Clinical Pharmacy Annual Meeting; 2011; Pittsburgh, PA. Abstract.

Breslin TM, Kulik AJ, Bugalski Stutrud CA, Bowers CJ, Smith GB, Mendez J, Afonso NM, Waites CC, O’Connell MB. Assessment of student pharmacist learning from a multidisciplinary older adult home visit. Presented at: American College of Clinical Pharmacy Annual Meeting; 2011; Pittsburgh, PA. Abstract.

Mendez J, Alfonso NA, Bruer S, O’Connell MB, Bugalski Stutrud C, Bridges PD. Introducing a multidisciplinary house call – the Wayne State university experience. Presented at: American Association of Medical Colleges; 2011; Denver, CO. Abstract.

Alfonso NA, Mendez J, O’Connell MB, Bugalski Stutrud C, Smith G, Waites C, Bowers C, Bruer S. Introducing interprofessional education using an older adult home visit. Presented at: Central Group on Educational Affairs; 2012; St. Louis, MO. Abstract.

Waites CC, Bowers C, Mendez J, O’Connell MB. Older adult home visiting: preparing students for future workforce roles on multidisciplinary teams. Presented at: Association for Gerontology in Higher Education Annual Meeting; 2012; Arlington, VA. Abstract.

Ali SQ, Spiteri KE, Bugdalski-Stutrud CA, Bowers CJ, Smith GB, Mendez J, Afonso NM, Waites CC, O’Connell MB. Contributions to patient care from P3 IPPE students during an interprofessional older adult home visit. Presented at: American Pharmacist Association Annual Meeting; 2012; New Orleans, LA. Abstract.

Rafie S, Choy K. Procedures to improve prescribing and dispensing of oral contraceptives at an academic medical center. Am J Health Syst Pharm 2012;69:249–52.

Rafie S, El-Ibiary SY. Student pharmacist perspectives on providing pharmacy-access hormonal contraception services. J Am Pharm Assoc 2011;51:762–5.

Shrader SP, Hall LN, Ragucci KR, Rafie S. Updates in hormonal emergency contraception. Pharmacotherapy 2011;31:887–95.

Whalen KL, Rose R. Estradiol valerate/dienogest: a novel oral contraceptive. Ann Pharmacother 2011;45:1256–61.

Presentations:
Julie Kelsey, PharmD:
presented “Drugs in Pregnancy” at the Virginia Health Department Clinician’s Conference
presented “Hypertension and Contraception” at the Virginia Health Department Clinician’s Conference.

Gerald Briggs, BPharm, FCCP:
presented “Perinatal Medications – Effects on the Neonate” to the faculty and students at Showa University, College of Pharmacy, Tokyo.

Other:
Leslie Richard, PharmD:
evaluated duration for several PSAP modules
Breakthrough Pain Treatment Pocket Card. Oxford University Press.

Gerald Briggs, BPharm, FCCP: helped initiate an online course in Obstetric Pharmacotherapy. The 2-unit elective course became available in January 2012 to pharmacy students at the College of Pharmacy, Washington State University. In the future, this course will be available to all colleges of pharmacy.